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INTRODUCTION 
 
Siddha system of medicine is one of the ancient system of medicine. The Siddhars 
laid the foundation for this system of medicine. Siddhars were spiritual adepts who possessed 
the Ashtma siddhi (eight super natural powers). The scientific knowledge of ancient Siddhars 
is marvelous and awe-inspiring; and their works are objects of great admiration at present. 
 The Siddha system of medicine has been evolved from a study of the special 
characteristics of the physical constitution of the people. The medicine prescribed in that 
science are herbs, bulbs and roots endemic to the region of Tamil Nadu and in abundance and 
agreeable to the nature of  the food suitable to their constitution and which the people are 
accustomed to. 
According to this system of medicine, health is defined as the state of physical, 
psychological, social and spiritual component of a human being. All the objects in this world 
either living or non-living are composed of five elements (IymBootham) namely; 
1. Man - Earth 
2. Neer - Water 
3. Thee - Fire 
4. Kaatru - Air 
5. Aagayam - Ether 
Physical health of human body is maintain by the three basic vital forces (humours) 
namely Vaatham, Pitham, Kabam called Uyirthathukkal which are activated by the function 
of Iymbootham (Five elements).  
When the above vital energy are affected or not in a balanced state they become 
Kuttrams which three disposes to diseases. The factors which affect this equilibrium are 
environment, climatic conditions, diet and abnormal physical activities etc. 
Diet and lifestyle plays a major role in health. Siddha system of medicine also 
emphasizes the importance of diet and lifestyle by the way of Pathiyam and Apathyam i.e, 
Do‟s and Don‟ts. To maintain a healthy life is based on the lifestyle, proper diet, normal 
habits, Yogasanas, Pranayamam etc. 
In Siddha system the diseases are classified according to Mukkutram theory and 
diseases are 4448 in numbers.  
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There are many diseases commonly affecting the middle age and elderly people. One 
among them is Kuthikaal Vaatham which is mainly interfering with the principle function of 
locomotion in human being. In this disease commonly heel is involved and in later stage it 
makes discomfort and disability to the individual. 
 I have interested to try effective remedy to Kuthikaal vaatham as said in Siddha 
literatures with the application of basic principles of Siddha and also supporting by Modern 
parameters.  
As per by the T.V. Sambasivam Pillai, Kuthikaal vaatham is a disease of the heel 
rendering one unable to rest on the heel owing to excessive neuralgic pain – Pododynia. Pain 
experienced in raising the toes and suddenly bringing the heels to the ground – Heel-Jar. 
Kuthikaal Vaatham may be compared with signs and symptoms of Plantar fasciitis in 
modern science. Plantar fasciitis is an aseptic inflammation of plantar fascia. It is pain in the 
heel, which is more in the morning. It gradually subsides as the patients take a few steps. The 
pain increases on prolonged standing, walking etc. It affects people in their active period of 
life and causes embarrassment both physically and mentally.  
It affects the both sex, approximately 10 % of general population particularly women 
in the age group  between 40 and 60 years are mostly affected.The prevalence rates of plantar 
fasciitis among a population of runners have been shown to be between 4% and 22%.  
The medicine choosen to this disease are Akkini Chooranam as Internal medicine and 
Veera Mezhugu as External application. In Akkini chooranam, most of the drugs having the 
actions of anti-inflammatory, anti-vaatha and analgesic properties. So I have choosen these 
drugs for my dissertation. 
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AIM AND OBJECTIVES 
 
AIM: 
         
          To evaluate the therapeutic efficacy of siddha drugs Akkini Chooranam (Internal)  and  
Veera Mezhugu (External) for the treatment of Kuthikaal Vaatham (Plantar fasciitis). 
  
OBJECTIVE: 
 
Primary Objective:   
To evaluate the efficacy of siddha drugs Akkini chooranam (Internal) and Veera 
Mezhugu (External) in reducing the pain and restricted movements in the treatment of 
Kuthikaal Vaatham (Plantar Fasciitis) through clinical study. 
Secondary Objective:   
           To study the other associated factors such as age, sex, BMI and occupation. 
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SIDDHA ASPECT 
 The concepts of Siddha system are based on fundamental principles of five basic 
elements, 96- Thathuvams, Three vital energy and Seven Thaathus (physical constituents of 
the body). 
 Vaatham, Pitham, Kabam are called as three vital energy of the human body. When 
the hormony of the above said vital energy get deranged owing to a relative increase or 
decrease of one or more of the principle vital energy, disease is caused. The normal ratio of 
Vaatham, Pitham, Kabam are 1:1\2:1\4 respectively. It is explained in the following verse, 
                      "ÅÆí¸¢Â Å¡¾õ Á¡ò¾¢¨Ã ¦Â¡ýÈ¡¸¢ø 
¾Æí¸¢Â À¢ò¾ó ¾ýÉ¢Ä¨Ã Å¡º¢ 
«ÆíÌí ¸Àó¾¡ É¼í¸¢§Â ¸¡§Ä¡Êø 
À¢Èí¸¢Â º£Å÷ìÌô À¢º¦¸¡ýÚ Á¢ø¨Ä§Â'' 
                                   - Ì½Å¡¸¼ ¿¡Ê 
 The alteration in the normal ratio produces disease. The signs and symptoms are 
produced according to the particular deranged kuttrams. 
 
KUTHIKAAL VAATHAM 
 A disease of the heel rendering one unable to rest on the heel owing to excessive 
neuralgic pain – Pododynia. 
 Pain experienced in raising the toes and suddenly bringing the heels to the ground – 
Heel-Jar. 
       -T.V. Sambasivam Pillai. (volume-2) 
 
 
 
 
 
9 
 
AETIOLOGY OF VAATHA DISEASES: 
According to Yugi Vaithya Chinthamani  
        "±ýÉ§Å Å¡¾ó¾¡ ¦ÉñÀ ¾¡Ìõ 
      Á¢Ìò¾¢§Ä ÁÉ¢¾÷¸Ùì ¦¸öÐ Á¡Ú 
À¢ýÉ§Å ¦À¡ó¾¨É§Â §º¡Ãï ¦ºöÐ 
      ¦ÀÃ¢§Â¡÷¸û À¢Ã¡Á½¨Ãò à‰ ½¢òÐõ 
ÅýÉ§Å Åî¦º¡ò¾¢ü §º¡Ãï ¦ºöÐ 
      Á¡¾¡À¢¾¡ ÌÕ¨Å ÁÈóÐ §À÷ìÌõ 
¸ýÉ§Å §Å¾ò¨¾ ¿¢ó¨¾¦ºö¾ §À÷ìÌí 
      ¸¡Âò¾¢ü ¸Äó¾¢Î§Á Å¡¾ó ¾¡§É.” 
"¾¡¦ÉýÈ ¸ºô§À¡Î ÐÅ÷ôÒ ¨ÃôÒ 
               º¡¾¸Á¡ö Á¢ïÍ¸¢Ûï º¨Áò¾ ÅýÉõ 
           ¬¦ÉýÈ Å¡È¢ÉÐ ¦À¡º¢ò¾ Ä¡Öõ 
¬¸¡ò §¾ÈÄÐ ÌÊò¾ Ä¡Öõ 
 À¡¦ÉýÈ À¸ÖÈì¸ Á¢Ã¡Å¢ Æ¢ôÒ 
      ÀðÊÉ¢§Â Á¢¸×Ú¾ø À¡Ã ¦Áö¾ø 
 §¾¦ÉýÈ ¦Á¡Æ¢Â¡ü §Áü º¢ó¨¾ Â¡¸¢ø 
      º£ì¸¢ÃÁ¡ö Å¡¾ÁÐ ¦ºÉ¢ìÌó ¾¡§É.” 
"¬½¡É ÅÃýÈ¦Éª§Â Á¾¢Â¡ Á¡ó¾÷ 
      «¸¾¢ÀÃ §¾º¢Â÷¸ð ¸ýÉ Á£Â¡÷ 
 §¸¡É¡É ÌÃ¦Á¡Æ¢¨Â ÁÈó¾ §À÷¸û 
       ¦¸¡¨Ä¸Ç× ¦À¡ö¸¡Áí ÌÈ¢ò¾ §À÷ìÌ 
 °É¡É º¼ó¾ýÉ¢ø Å¡¾õ ÅóÐ 
        ¯üÀÅ¢ìÌõ §Å¾ò¾¢ Öñ¨Á ¾¡§É."  
        The above line indicates, those who disrespect the parents, teachers, insulting the elders,   
blaspheming the Holy books - having cruel in their thoughts daytime and sleeplesness at 
night will get Vaatha diseases. Increased intake of bitter, astringent, sour type of foods, 
increased intake of water, excessive starvation, increased sexual activities will produce 
Vaatha diseases. 
 
According to the text ‘Pararasasekaram’ 
¦¾¡Æ¢ø ¦À¡Ú¨¸ôÒì¸¡÷ò ¾øÐÅ÷ò¾ø Å¢ïÍ¸¢Ûï§º¡Úõ 
À¨ÆÂ¾¡õ ÅÃÌ Áü¨Èô ¨Àó¾¢¨É ÂÕó¾¢ É¡Öõ 
±Æ¢ø¦ÀÈô À¸Ö Èí¸¢ þÃÅ¢É¢ ÖÈí¸¡ ¾¡Öõ 
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Á¨Æ¿¢¸÷ ÌÆÄ¢ É¡§Ç Å¡¾í§¸¡ À¢ìÌí ¸¡§½. 
¸¡½§Å Á¢¸×ñ ¼¡Öí ¸ÕÐÀð ÊÉ¢Å¢ð ¼¡ 
Á¡É¨É Â¡÷¸ñ §Á¡¸ ÁÈì¸¢Û Á¢Ìó¾¢ð¼¡Öõ 
¬½Å ÁÄí¸ ¼õ¨Á Âí¹§É Å¢¼¡¾ ¾¡Öõ 
Å¡Û¾ý Á¼¿ø Ä¡§Ç Å¡¾í§¸¡ À¢ìÌí ¸¡§½.  
À¡Ã¢É¢ü ÀÂôÀð¼¡Öõ ÀÄÕ¼ý §¸¡À¢ò ¾¡Öõ 
¸¡¦ÃÉì ¸Õ¸¢ §Â¡Êì ¸ØÁÃò ÐÃò¾¢ ½¡Öõ 
²÷¦ÀÚ ¾ÉÐ ¦¿ïº¢ý Á¢¸òÐì¸ Á¨¼ó¾¢ð¼¡Öõ 
À¡Ã¢Â¸¡üÈ¢ É¡Ùõ À¼Ã¢Ûõ Å¡¾í ¸¡Ïõ. 
¸¡Äí¸ñ Á¡È¢ ÔñÏí ¸¡Ã¢Âò ¾¡Öó ¾ñ½£÷ 
º¡Ä§Å ÂÕó¾¢ ½Öï ºó¾¢Â¢ Öð¸¡÷ó ¾¡Öõ 
§¸¡ÄÁ¡õ ÒÇ¢ôÒ ¦¿ö¨Áì Ì¨ÈÅÈ ÅÕó¾¢ É¡Öõ 
Å¡ÄÅ¡÷ Ó¨Ä¿ø Ä¡§ÇÅ¡¾Óü ÀÅ¢ìÌí ¸¡§½. 
¯üÀÅ¢ò ¦¾ØÁô §À¡§¾ ÔÂ÷ÒÈò ÐÊ¨Âô ÀüÈ¢ò 
¦¾üÀÈì Ì¨¼óÐ §¿¡×ï ¦ºöÐ§ÁÄ §¿¡ìÌ Á¡¸¢ø 
Å¢ü¦À¡Ä¢ Ñ¾Ä¢ É¡§Ç §ÁÄ¢Îí Ì½í¸ ¼õÁ¢ø 
¦º¡ü¦ÀÚ Å¡¾õ §¾¡ýÚ¦Áý ÈÈ¢óÐ ¦¸¡û¸  
¦¾Ã¢óÐÓý ¦º¡ýÉ Åñ½ï ¦ºöÂ¸¡ ÄÊ¨Âô ÀüÈ¢ 
Á¡ó¾¨Éô §À¡üÈ¢ Á¢÷òÐ ÁüÚ§Áø §¿¡ìÌ Á¡¸¢ø 
«ÃýÈ¨Éò Ð¾¢Â¡ Á¡ó¾ ÃÛºÃ¢ì ¸¢ýÈ §¸¡Â¢ø  
          ºÃ¢ó¾¢Îí ÌÆÄ¡ö Å¡¾í ÌÊÒÌï º¡üÚí ¸¡§Ä. 
  
According to the text, indicates the intake of acrid, bitter taste, pungent content foods, 
intake of grains, sleep in day time and instead loss of sleep in night time. Increased intake of 
food, frequent exposure to starvation, excessive sexual activities, increased fear, increased 
anger, increased sadness, and high exposure to air, alteration in taking of diet timings will 
produce Vaatha diseases. 
 
In the text ‘Agathiyar Kanma Kaandam’ 
"á¦ÄýÈ Å¡¾õÅó¾ Å¨¸ ¾¡§ÉÐ 
                Ññ¨ÁÂ¡öì ¸ýÁò¾¢ý Å¨¸¨Âì§¸Ù 
¸¡Ä¢§Ä §¾¡ýÈ¢ÂÐ ¸ÎôÀ§¾Ð 
                ¨¸¸¡Ä¢ø Ó¼ì¸¢ÂÐ Å£ì¸§ÁÐ 
§¸¡Ä¢§Ä ÀÎì¸¢ýÈ Å¢ÕðºÁ¡É  
                ÌÆó¨¾ÁÃó ¾¨É¦Åð¼ø §Áø§¾¡ø º£Åø 
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¿¡Ä¢§Äº£Å ¦ºóÐ ¸¡ø ÓÈ¢ò¾ø 
                 ¿øÄ¦¸¡õÒ ¾¨ÆÓÈ¢ò¾ø ¿Ä¢ò¾ø ¸¡§½." 
          The above text indicates Cutting young trees, peeling the wood bark, fracturing the legs 
of animals will produce Vaatha diseases. 
According to the text Sarabenthirar Vaithiya Muraigal- Vaatha Rokha Sikitchai 
 Consuming low quantity of food 
 Sexual indulgence 
 Decreased sleep 
 When more or less in taking purgation,emetics 
 Taking more times of Blood letting therapy 
 Doing heavy work 
 Weakness due to sorrow, diseases, worries 
 Control of reflexes like feaces, urination 
 Conversion of undigested food juices into toxic substances(aamam) 
 Trauma 
 Control of hunger 
 Injuries in uyirnilaigal 
 Falling down from vehicle 
 Doing heavy works 
All these activities lead to the low level of saaram in ducts. So as to compensate this 
more of vaayu‟s were produced and affect one or more organs. 
FACTORS THAT INFLUENCE THE VAATHA TYPE OF DISEASE: 
 Seasons which deranges Vaatham : 
In Muthuvenil kaalam, the solar radiation increases the evaporation of water content 
from the earth in turn produces dryness. Similarly the dryness is produced in our body and 
causes vaatha diseases. 
A) Diets which deranges Vaatham: 
          According to the text ‘Sababathi Kaiyedu’ 
                "ÅÇ¢ ¾Õ ¸¡ö¸¢ÆíÌ Å¨ÃÅ¢Ä¡ ¾Á¢Äø §¸¡¨Æ 
                 ÒÇ¢ ¾Â¢÷ §À¡ýÁ¢ÌìÌ Ó¨ÈÂ¢Ä¡ ×ñÊ §¸¡¼ø 
                 ÌÇ¢÷¾Õ ÅÇ¢Â¢ü §È¸í ÌÉ¢ôÒÈ ×ÄÅø ¦ÀñÊ÷ 
                 ÌÇ¢¾Õ ÁÂì¸õ ¦Àü§È¡÷ ¸Ê¦ºÂø ¸ÕÅ¢Â¡Áø." 
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            The excessive intake of tubers food items, irregularity in taking foods, consume curd, 
acrid food items, higher exposure to wind, living in higher altitudes, increased sexual desire, 
and increased exposure to chill weather will aggravate Vaatha diseases. 
B)  Habitual characters which deranges Vaatham: 
              InTheraiyar vagadam , 
                “¦ÅöÂ¢Ä¢ø ¿¼ì¨¸sÂ¡Öõ Á¢¸ò¾ñ½£÷ ÌÊì¨¸Â¡Öõ 
                 ¦ºöÂ¢¨Æ Á¸Ç¢É¨Ãî §º÷ó¾ÛÀ Å¢ì¨¸Â¡Öõ 
                 ¨ÀÂ§É ¯ñ¨ÁÂ¡Öõ À¡¸ü¸¡ö ¾¢ý¨¸Â¡Öõ 
                 ¨¾Â§Ä Å¡¾§Ã¡¸õ ºÉ¢ìÌ¦Áý ÈÈ¢óÐ ¦¸¡û§Ç.” 
             Walking in direct exposure to sunlight, excessive intake of water, sexual indulgence, 
intake of bitter guard will leads to Vaatha diseases. 
SEATS OF THE THREE HUMORS:  
    ‚ÅÇ¢Ó¾Ä¡ ¦Âñ½¢ÂÓì ÌüÈ ¦ÁøÄ¡õ 
         Å¡úÅ¦¾Ûõ §¾¸ÓüÚõ ÀõÀ¢ô ÀÃóÐ 
    ¦¾Ç¢×Èî º¡üÚõ¿¡À¢ì Ìì¸£ú Å¡¾õ 
            ¾£Â¢ýÜ È¡ÁÆ§Ä¡ ¯ó¾¢ Â¡Å¢ì....‛ 
                                       (ÁÕòÐÅò ¾É¢ô À¡¼ø) 
  Vaatham, pitham, kabam are the three important humors of human body. These three 
humors are present all over the body. Among three Vaatham are more predominant in below 
the umbilicus, Pitham in abdomen and thorax, kabam are predominant in head and neck 
region.             
 GENERAL CHARACTERS OF VATHA DISEASES 
     ‚Å¡¾õ ÅóÐüÈ §À¡Ð ÅÂ¢ÈÐ ¦À¡ÕÁ¢ì ¦¸¡ûÙõ 
            ¾¡¾Å¢úó¾¢ÎôÒ ¨¸¸¡ø ºóÐ¸û ¸ÎôÒ §¾¡ýÚõ 
      º£¦¾¡Õ ÁÄÓ ¿£Õó º¢ÚòÐ¼ý ¸ÎòÐ Å¢Æ 
            Á¡¾ÅÁ¨Ã §Áø Åó¾ Å¡¾ò¾¢ý Ì½Á¢¾¡§Á.‛ 
           -  Yugi Munivar Perunool Kaaviyam   
Based on the text Yugi Munivar Perunool Kaaviyam Vaatha diseases are 
characterized by pain and swelling in joints, abdominal distension, constipation and burning 
micturition. 
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 “¸¡½ôÀ¡ Å¡¾Á£È¢ø ¸¡ø¨¸¸û ¦À¡ÕòÐ §¿¡×õ 
  Â½ôÀ¡ Ì¼ø ÒÃðÎõ ÁÄºÄõ ¦À¡ÕÁ¢ ¸ðÎõ 
  °½ôÀ¡ ÌÇ¢Õí ¸¡öîºø ¯¼õ¦ÀøÄ¡õ ÌòÐ Å¡ö× 
  Å£½ôÀ¡ Ì¾Á¢ÚìÌõ Å¢Â÷¨ÅÔõ §Å÷ìÌõ ¾¡§É.” 
                -  Agathiyar Vaithiya Kaaviyam -1500 
 Joint pain, nausea, constipation, oliguria, fever, rigor and sweating are produced due 
to vitiated vaatham. 
IN THAERAYAR VAAGADAM: 
          "Å¡¾Å£Ú «ýÉÁ¢Èí¸¡Ð ¸ÎôÒñ¼¡õ Åñ½Óñ¼¡õ 
      §Á¡Ð¸ðÎ ¦Ã¡¸õ ÍÃÓñ¼¡ Á¢ÕÁÖÁ¡ ÓÈí¸¡§¾ýÚõ 
      µÐ ÝÃ¢Â Å¡¾ ÁÉÄ¡Ì ¿Îì¸ Óñ¼¡õ §À¡Õû¸Ç¡öò 
      ¾£¾É§Å ¿ÃõÀ¢º¢òÐ ºóÐ¸û §¾¡Úí ¸ÎìÌõ ¾¢ÉÓó¾¡§É" 
                             - Thaerayar Vaagadam 
 According to the Thaerayar Vaagadam, Loss of appetite, pain and redness, fever, 
cough, insomnia, shivering, pain in all joints is the characteristic features of vaatha diseases, 
which are mentioned in above text.  
PROPERTIES OF VAATHAM: 
          ‚´ØíÌ¼§É ¾¡§¾ú ãî§º¡í¸¢ þÂí¸ 
                ±Øîº¢¦ÀÈ ±ôÀ½¢ÔÁ¡üÈ -±Øó¾¢Ã¢Â 
          §Å¸õ ÒÄý¸ÙìÌ §ÁÅî ÍÚÍÚôÒ 
                 Å¡¸Ç¢ìÌõ Á¡ó¾÷ìÌ Å¡Ô‛ 
                                                  - Á.¾.À¡ 
        The following are the natural properties of Vaatham. 
1. To stimulate 
2. Respiration 
3. To activate the Body, Mind and the Intellect. 
4. To expel the fourteen different kinds of natural reflexes. 
5. To activate the seven physical constituents in functional co-ordination. 
6. To strengthen the five sense organs. 
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In the above processes Vaatham plays a vital role to assist the body functions. 
Dearanged vaatham causes the following symptoms 
1. Body ache and pain, 
2. Pricking pain, 
3. The pain as though the body is tightly bounded by cords, 
4. Nervous debility, 
5. Tremor, 
6. Rigidness, 
7. Dryness 
8. Debility (Emaciation), 
9. Throbbing pain (restriction of movements), 
10. Trauma, 
11. Displacement of joint (dislocation of joint), 
12. Weakness of functional organs and loss of functions, 
13. Loss of sensation or perception of astringent taste only, 
14. Constipation ,concentrated urination, 
15. Thirst, 
16. Sensation of fragility in the foreleg and thigh, 
17. Numbness and pricking pain in the bones, 
18. Goose skin, 
19. Stiffness of upper and lower limbs and back, 
20. The skin, eyes, faeces and the urine are the black in colour. 
CLINICAL FEATURES: 
According to Yugi Vaithiya Chinthamani the following clinical features were seen:  
 Stiffness of the body 
 Sweating, body pain 
 Paleness of the body 
 Yellowish discolouration of stools and urine. 
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KINDS OF VAATHAM:  
          Ó¨È¨ÁÂ¡õ À¢Ã¡½§É¡¼À¡Éý Å¢Â¡Éý 
               ã÷ì¸Á¡ Ó¾¡É¦É¡Î ºÁ¡É É¡¸ý 
          ¾¢È¨ÁÂ¡í Ü÷Á§É¡Î ¸¢Õ¸ ÃýÈ¡ý 
               §¾Å¾ò¾ ¦É¡Î¾ÉïºÂÛ Á¡Ìõ   - 
                                               (Ô¸¢ÓÉ¢ º¢ó¾¡Á½¢ 800) 
  Even though the vaatham seems to be the same, it has got ten different forms and 
actions. 
TEN DIFFERENT KINDS OF VATHAM: 
Praanan                        -Air of life 
Abaanan                      -Air with downward motion (Flatus Air) 
Viyaanan                     -Air which spreads throughout 
Udhaanan                    -Air with upward motion 
Samaanan                    -Air with upward and downward motion 
Naagam                       -Air of higher intellectual function 
Koorman                    -Air of yawning 
Kirukaran                  -Air of salivation 
Devathatthan          -Air of laziness 
Dhananjayan            -Air that acts on death 
SIDDHA PATHOPHYSIOLOGY: 
  Changes in lifestyle, occupation, food and other habits lead to development of this 
disease by causing derangement of muththaathus. Improper food habits alter the elemental 
composition directly while the other causes lead to derangement of these elements indirectly. 
When the elemental composition is altered, the uyir thaathukkal or the three humours which 
are made up of these elements naturally also get deranged. This simultaneously leads to 
derangement of seven udal thaathukkal, which produces symptoms of the disease „Kuthikaal 
vatham‟. 
DIAGNOSIS 
 Diagnosis of „Kuthikaal vaatham‟ in Siddha is based on Envagai thervugal and also 
on the other factors like 
1. Uyirthaathukkal  
2. Udalthaathukkal 
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3. Gnanenthiriyam 
4. Kanmenthiriyam 
ENVAGAI THERVUGAL: 
         It is a unique diagnostic method of siddha medical system. They are , 
                   ''¿¡ÊôÀÃ¢ºõ ¿¡¿¢Èõ ¦Á¡Æ¢Å¢Æ¢ 
    ÁÄõ ãò¾¢ÃÁ¢¨Å ÁÕòÐÅÃ¡Ô¾õ'' 
''¦ÁöìÌÈ¢ ¿¢Èó¦¾¡É¢ Å¢Æ¢¿¡Å¢ÕÁÄõ ¨¸ìÌÈ¢'' 
                                  -§¾¨ÃÂ÷ 
1. NAADI: (PULSE) 
In kuthikaal vaatham, the following types of Naadi could be felt. They are 
Vathapitham, Pithavaatham, vathakabam, Kabavatham. 
2. Sparism  – Test sensation, temperature and nature of the skin  
3. Naa   – Test theColour of saliva, colour of sputum and nature of speech. 
4. Niram             – Test theVariation in pigmentation of skin. 
5. Mozhi          
- Vatham (Normal voice) 
- Pitham (High pitched voice) 
- Kabam (Low pitched voice)  
- Thontham (Mixed all the above) 
6. Vizhi 
- Vatham (Black in colour, increased lacrimation)) 
- Pitham (Yellow or red in colour) 
- Kabam (White in colour)  
7. Malam         -    Vatham (Stools are black in colour and constipated) 
- Pitham (Yellowish white in colour) 
- Kabam (White in colour)  
- Thontham (Mixed colour) 
8. Moothiram 
 Collection of urine for the determination of Neerkkuri and Neikkuri, is an important 
diagnostic method Neerkkuri  
 Prior to the day of urine examination the patient is instructed to take a balanced diet. 
The patient should have good sleep. After waking up in the morning, the first urine voided is 
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collected in a clear wide mouthed glass container and is subjected to analysis of “Neerkkuri” 
within one and a half an hour. 
 Neikkuri 
 The collected specimen (Urine) is kept open in a glass dish or china clay container. It 
is to be examined under direct sunlight, without any shaking of the vessel. 
  Then add one drop of gingelly oil without disturbing the urinary specimen and the 
Neikkuri was noted in direct sunlight and conclude the diagnosis as follows,  
Character of Vaathaneer 
 “அரவென நீண்டினஃதே ொேம்” 
 When the oil drop lengthens like a snake, it is called “VaathaNeer” 
Character of Pithaneer 
 “ஆழி தபாற்பரெின் அஃதே பித்ேம்” 
 When the oil drop spreads like a ring, it is called “Pitha neer 
Character of Kabaneer 
 “முத்வோத்து நிற்கின் வ஫ாழிெவேன் கபத஫” 
 When the oil drop appears like a pearl, it is called “Kaba neer” 
Character of Thonthaneer 
 “அரவிலாழியும் ஆழியில் அரவும் 
 அரவின் முத்தும் ஆழியில் முத்தும்  
 ததாயிற்றில் ததாந்த ததாடங்களாதே”  
 Snake in the ring, ring in the snake, snake in the pearl and ring in the pearl are the 
characters of Thontha neer.  
 
THREE UYIR THAATHUKKAL 
1. Vaatham 
 In Kuthikaal vaatham patients among the ten types of vaatham; the following types 
are affected and causing symptoms accordingly. 
1. Abaanan - Affected (causing constipation) 
2. Viyaanan - Affected (producing pain, restriction of joint movements) 
3. Samaanan - Affected (deranging the other four types of vatham) 
4. Devathathan - Affected (causing sleep disturbance) 
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2. Pitham 
   Among the Five types of pitham (Analaagam, Ranjagam, Pirasagam, Alosagam and 
Saathagam) the Saathaga pitham only affected in Kuthikaal vaatham patients and causing 
difficulty in walking, standing, difficulty in walking after getting up from bed in the morning. 
3. Kabam 
 In the five types of Kabam (Avalambagam, Kilethagam, Pothagam, Tharpagam and 
Santhigam) avalambagam and Santhigam only affected in Kuthikaal vaatham patients and 
causing pain in heel region and restriction of movements in the both heel and ankle region. 
SEVEN UDAL THAATHUKKAL: 
Among the seven Udal Thaathukkal (Saaram, Senneer, Oon, Kozhuppu, Enbu, Moolai and 
Chukkilam/Suronitham) the following four are commonly affected in Kuthikaal vaatham 
patients. 
1. Saaram - Tiredness and weakness 
2. Oon- Plantar fascia weakness 
3. Kozhuppu - Pain in heel region, restriction of movements. 
4. Enbu - Weakness of bone 
GNANENTHIRIYAM 
 The Kuthikaal Vaatham patients are having the clinical features of pain and tenderness 
especially in heel region. These are felt through Mei. 
KANMENTHIRIYAM 
 In Kuthikaal Vaatham patients, Kaal is affected. This is due to pain, difficulty in 
walking etc. Eruvai affected – difficulty in passing stools. 
NOI KANIPPU VIVATHAM (DIFFERENTIAL DIAGNOSIS) 
Some types of Vaatha diseases are mimicking like Kuthikal vaatham. Careful and 
clear history taking and examination will reveal the correct diagnosis. 
They are:      
A. Vaathathambam 
B. Vaathakarshanam 
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A. VAATHASTHAMBAM: 
 
 ¯üÀÅ¢ìÌõ Å¡¾ÁÐ ±ØóÐ ¦À¡í¸¢ 
¯Â÷¸¡Ä¢ý ÒÈÅÊ¨Âì Ì¨¼óÐ ÀüÈ¢ 
¦¾üÀÅ¢ìÌõ Å£ì¸Á¡öî ¦ºØõÀ Öñ¼¡öò 
§¾¸¦ÁíÌ §¿¡Å¡¸¢ò ¾¢Á¢Õ Á¡¸¢ 
Å¢üÀÅ¢ìÌõ Å¢øÖ§À¡ø Å¢¾É Á¡¸¢ 
Á¢Îì¸¡É Á¡ó¾¨Éô§À¡ø Å¢¾É Á¡¸¢ô 
ÀüÀÅ¢ìÌõ ÀÃýÈ¨É§Â ¿¢¨ÉÂ¡ ã¼÷ 
ÀÎ¸¢ýÈ Å¡¾Š¾õ ÀÓÁ¡õ À¡§Ã 
                       -ä¸¢ÓÉ¢ 
  
 Pain in sole region 
 Burning sensation  
 Oedema 
 General body tiredness 
 Stiffness 
 Opisthotonus condition 
Even though pain in the sole region is mentioned here, the other symptoms are not relevant to 
kuthikaal vaatham. So I differentiate kuthikaal vaatham from vaathasthambam. 
 
B. VAATHAKARSANAM: 
 
À¡÷ì¸¢ýÈ Å¡¾×û ÇÊÂ¢ü º¡½¢ 
À¾¢òÐ¨Åò ¾Ð§À¡Äô À¡¾ ¦ÁíÌõ 
§¿¡ì¸¢ýÈ Ì¾¢ÉÃõÒì ¸¡ø¸ ¦ÇíÌõ 
¦¸¡Ê¾¡É À¡ÃÁ¡öò ¾¢Á¢÷ô Òñ¼¡¸¢ 
Å¡÷ì¸¢ýÈ Å¡÷ò¨¾¸û Á¢¸§Å ¦ºöÐ 
Å¨Çó¾¢ÊÛ ¿¢Á¢÷ó¾¢ÊÛõ Åºí¦¸¡ ¼¡Áø 
²÷ì¸¢ýÈ ¸¡Ö¨ÇìÌõ Å¡¾ ¸÷„½õ 
®¾ÄÈ Á¢øÄ¡¾¡÷ì ¦¸öÐí ¸¡§½ 
                   -ä¸¢ÓÉ¢ 
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 Feeling of dung like substance applied in the soles. 
 Pain in heel region 
 Heaviness 
 Stiffness 
 Difficulty in forward bending posture 
Even though pain in the heel region is mentioned here, the other symptoms are not relevant to 
kuthikaal vaatham. So I differentiate kuthikaal vaatham from vaathakarsanam. 
 
LINE OF TREATMENT 
In Siddha system, the treatment is based on mukkutram theory. The line of treatment 
plays an important role in the normalization of  mukkutram. Treatment is not only for curing 
the disease but also for the prevention recurrence of the symptoms and rejuvenation of 
udalkattugal. These are  
   
1) Kaappu(Prevention) 
2) Neekkam(Treatment) 
3) Niraivu(Restoration) 
Kaappu (Prevention) 
The prevention of diseases were well said in the Siddha system of Medicine as 
mentioned in the text „Theraiyar Pinianugaa Vithi’ 
    ‘À¡Öñ§À¡õ ±ñ¦½ö¦ÀÈ¢ý ¦Åó¿£÷ ÌÇ¢ô§À¡õ 
    À¸üÒ½§Ã¡õ; À¸üÚÂ¢ø§Å¡õ: À¡§Â¡¾ÃÓ ãò¾ 
    ²Äï§º÷ ÌÆÄ¢Â§Ã¡ ÊÇ¦ÅÂ¢Öõ Å¢Õõ§À¡õ; 
    -Ãñ¼¼ì§¸¡õ; ´ý¨ÃÅ¢§¼¡õ; -¼Ð¨¸Â¢ü ÀÎô§À¡õ’ 
The preventive methods for kuthikaal vaatham are; 
 Control the body weight by diet and exercise 
 Avoid excessive intake of salty, sour, tinned food items. 
 Modify the nature of work which gives stress to a heel region.                               
 Avoid prolonged standing and long distance walking. 
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NEEKKAM (TREATMENT) 
In Siddha Maruthuvanga Churukkam, the deranged Vaatha can be balanced by 
purgation hence to start with……. 
                  ‘‘Å¢§ÃºÉò¾¡ø Å¡¾ó ¾¡Øõ‛ 
Followed by usage of Internal and external drugs. 
  On first day: - Purgation: 
            Meganatha kuligai – 2 with hot water early morning in empty stomach. 
             Internal drug: 
    Akkini Chooranam – 1.5 grams, twice a day. 
             External drug: 
                       Veera Mezhugu – Q.S  is given for external application over the affected area. 
 
NIRAIVU (RESTORATION) 
 The diet should be normalizes the Vaatha and also strengthen the body. 
 
DIETARY REGIMENS: 
Avoid: 
 Tubers except karunai kizhangu(Colocasia antiquorum) 
 Maaporulghal(Carbohydrates) 
 Vaazhaikkai (Musa paradisiaca) 
 Kaaramani (Vigna unguiculata) 
 Verkkadalai (Arachis hypogea) 
 Pattaani (Pisum sativum) 
 Mochai (Lablab purpureus) 
 Kezhvaragu (Eleusine coracana) 
 Kambu (Pennisetum typhoideum) 
 Solum (Sorghum vulgare) 
 Sour, astringent foods 
 
       During medication, should not sleep in day times, avoid sexual indulgence. Due to 
these activities excessive heat will be produced by sleep, sun heat, dietary regimen will 
causes the diseases. 
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MODERN ASPECT 
PLANTAR FASCIA 
ANTOMY OF PLANTAR FASCIA: 
 The plantar fascia is the investing fascial layer of the plantar aspect of the foot that 
originates from the os calcis and inserts through a complex network to the plantar  forefoot.  
It is a tough, fibrous layer, composed histologicallly of both collagen and elastic fibers.  The 
terms planar fascia and plantar aponeurosis are often used interchangeably, although strictly 
speaking only the central part of the plantar fasia is extensively aponeurotic.  It is analogous 
to the plantar fascia of the hand.  The plantar fascia is thick structure, and not only serves a 
supportive ad protective role, but is also intricately involved with the weight-bearing function 
of the foot.  
 It is divided into three major areas. 
 Central portion  
 Medial portion 
 Lateral section 
Central portion:  
The central portion is the major portion of the plantar fascia both anatomically and 
functionally.  This portion is the thickest and strongest and is narrowest proximally where it 
attachés to the medial process of the calcaneal tuberosity, proximal to the flexor digitorum 
brevis.  This attachment site is often involved in a condition called plantar heel pain  how 
ever, pain can occur anywhere along the structure.  From its insertion, the cental portion of 
the fascia fans out and becomes thinner distally.  Its fibers are longitudinally oriented and 
adhere to the underlying flexor digitorum brevis muscle.  The central portion envelops the 
flexor digitorum brevis muscle on both the sides, forming the medial and lateral inter 
muscular septums, which anchor the plantar fascia to the deep plantar pedis.  At the mid shaft 
of the second to fifth MTP joint, the body of the central portion branches into five superficial 
longitudinal tracts.  All five superficial longitudinal tracts terminate by inserting into,  and 
blending with, overlying subcutaneous tissue and skin.  Due to the anatomical connections of 
the central portion, dorsiflexion of the toe slides the plantar pads distally placing tension on 
the plantar aponeurosis.  The central portion of the fascia primarily functions as a dynamic 
stabilizer of the medial longitudinal arch during weight-bearing activities. 
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Lateral and medial portions: 
 The smaller and thinner lateral and medial portions are thin and cover the under 
surface of the abductor digiti minimi and abductor hallucis muscles, respectively.  
 
     
                                  
 
CENTRAL, LATERAL AND MEDIAL PORTIONS OF THE PLANTAR FASCIA 
 
PLANTAR FASCIITIS 
Plantar heel pain is defined as, pain arising from the insertion of the plantar fascia, 
with or without heel spur and has been experienced by 10% of the population.  The condition 
often referred to as plantar fasciitis, is an inflammatory process. This is an annoying and 
painful condition that limits function.  There is pain and tenderness in the sole of the foot, 
mostly under the heel, with standing or walking.  The condition usually comes on gradually, 
without any clear incident or injury but sometimes there is a history of sudden increase in 
sporting activity, or a change of footwear, sports shoes or running surface.  There may be an 
associated tightness of the Achilles tendon.  
 The pain is often worse when first getting up in the morning, with typical hobbling 
downstairs, or when first getting up pain and stiffness.  The pain can at times be very sharp, 
or it may change to a persistent back ground ache as the patient walks about.  The condition 
can take 18-36 months or longer to resolve, but is generally self-limiting, given time. 
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Epidemiology:  
A survey of US professional football, baseball, and basketball team physicians and 
trainers found that plantar fasciitis was among the 5 most common foot and ankle injuries 
observed in professional athletes.  It is estimated that approximately 1million patient visits 
per year are due to plantar fasciitis.  Plantar fasciitis accounts for about 10% of runner-related 
injuries and 11-15% of all foot symptoms requiring professional care.  It is through to occur 
in 10% of the general population as well.  It may present bilaterally in a third of cases. 
ETIOLOGY OF PLANTAR HEEL PAIN 
 Etiology of plantar heel pain is poorly understood, although a number of factors have 
been proposed 
 Obesity: 
Obesity has been shown to occur in 40% of men and 90% of women with 
plantar heel pain.  A body mass index greater than 30kg/m
2 
increases the risk of 
developing plantar heel pain. 
 Occupational: 
There is an association between plantar heel pain and prolonged standing or 
walking (“policeman‟s heel”), or a sudden changes in the stresses placed upon the 
feet likening this condition to other repetitive stress disorders such as carpal tunnel 
syndrome and tennis elbow. 
 Acute injury: 
Although less common, plantar heel pain may be associated with n acute 
injury to the heel. Some people recall stepping on a pebble, or other hard object, 
before pain began (“stone bruise”). 
 Inflammatory spondyloarthropathies: 
These disorders should be considered when multiple joints or areas are 
involved. Upto 16% of patients presenting with subcalcaneal pain will later be 
diagnosed with a systemic arthritic disorder. 
 Calcaned stress fracture: 
The history for calcaneal stress fractures usually involves a sudden increase in a 
running activity, such as that seen in a military recruit at boot camp or a reservist. 
 Nerve entrapment 
 Tumors 
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 Infections 
 Neuropathy (diabetic, alcoholic) 
 The fat-pad syndrome 
 Night splinting 
 Orthotics 
 Heel cups/taping 
 Stretching and strengthening 
 Deep frictional massage 
 Corticosteroid injection 
 Shoe modification 
 Casting 
 
Types of the plantar fasciitis 
 Insertional plantar fasciitis : 
It is otherwise called the „Heel pain syndrome‟.  Pain is felt at the medial  
calcaneal tubercle (point tenderness). 
 Diffuse plantar fasciitis: 
Pain felt diffusely over the heel and the sole of the foot. 
PATHOLOGY: 
 Plantar fasciitis is an aseptic inflammation of the plantar fascia. The lesions affect the 
soft tissues at the site of attachment of the plantar aponeurosis to the inferior aspect of the 
tuberosity of the calcaneus. The spur is not a growth but a reaction to the local inflammation 
of the plantar fascia. The severity of the pain is not proportional to the size of the spur. Even 
big spurs may be asymptomatic and minimal spurs may be associated with severe pain. 
PATHOMECHANISAM:  
The functions of the plantar fascia are to support the medial longitudinal arch during 
static and dynamic loading of the foot, and to provide midfoot stability. It also assists the heel 
pad in dynamic shock absorption. Just after heel strike during the first half of the stance phase 
of the gait cycle, the tibia turns inward and the foot pronates to allow flattening of the foot. 
This stretches the plantar fascia. The flattening of the medial longitudinal arch allows the foot 
to accommodate the irregularities in the walking surface and also to absorb shock. 
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The plantar fascia functions throughout the windlass mechanism to limit the flattening 
of the foot and to elevate and stabilize the medial longitudinal arch. This occurs when the 
toes are dorsiflexed and passively pulling the plantar fascia under the metatarsal heads.  Thus, 
each time the foot passes from heel rise to toe off in the stance phase of the gait cycle, the 
plantar fascia is placed under increased tension. 
Mechanistically, hicks appears to be the first to describe the windlass mechanism  by 
which passive dorsiflexion of the toes causes the medial longitudinal arch to rise, the hind 
foot to supine, the leg to externally rotate, and the plantar fascia to become more tense than 
when the foot an toes are in neutral. So that the plantar fascia act as a cable that is wound 
around the metatarsal head, which acts as a drum, with the proximal phalanx acting as a 
handle to provide the winding.  The plantar fascia is prone to repetitive injury at the posterior 
insertion due to its role in maintain the medial longitudinal arch and through the stress placed 
on it by the shock absorbency function of heel.  If there is a predisposing or aggravating 
factor, the repetitive traction placed on the plantar fascia during walking or running may lead 
to micro and macro tears, which induce a reparative inflammatory response.  The heeling 
response is then interrupted by the continued stress produced by weight bearing, resulting in 
chronic degenerative changes.   
Histological changes include collagen necrosis, angiofibroblastic hyperplasia, 
chondroid metaplasia and matrix clacification may occur. Pathologically, prolonged 
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inflammatory changes in the tissue are seen initially as edema, and are seen later as 
thickening of the plantar fascia.   
CLINICAL FEATURES: 
Pain in the heel, which is more in the morning.  It gradually subsides as the patient 
takes a few steps.  The pain increases on prolonged standing, walking, etc. 
DIAGNOSTIC CRITERIA: 
 Radiographs 
 Consisting of the routine Anterio posterior, lateral and oblique view is advised.  
However, the X-ray does not show any changes in plantar fasciitis.  It helps to detect 
calcaneal spur and other heel pathologies. 
 MRI 
 It can be helpful in excluding a calcaneal fracture, which is an important differential 
diagnosis. 
DIFFERENTIAL DIAGNOSIS: 
 The fat-pad syndrome  
 Nerve entrapment 
 Calcaneal fracture  
 Inflammatory spondyloarthropathies  
 Psoriatic arthritis 
 Rheumatoid arthritis 
 Trauma 
 Tumor  
 
MANAGEMENT: 
 Rest  
 Shoes with soft rubber pads  
 Heat therapy 
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DRUG REVIEW  
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PROPRTIES OF TRIAL DRUGS 
 
1. KODIVELI – Plumbago zeylanica, Linn.   
 Family : Plumbaginaceae 
 Useful part : Root 
Organoleptic characters: 
  Taste  : Acrid 
  Potency : Veppam 
  Division : Acrid  
 Actions : Antipyretic 
   It is indicated for bodyache, vaatham and cancer. 
 
Chemical constituents: 
Two new quinines – Zeylanone, isozeylanone, plumbagic acid, plumbagin, b-
sitosterol, vanilic acid, steroidal glycoside. 
 
Pharmacological activity: 
 Anti-inflammatory, analgesic and antipyretic activity. 
 Plumbagin inhibits LPS – induced inflammation through the inactivation of 
nuclear factor-kappaB and mitogen activated protein kinase signalling 
pathway  
                                (Food chem toxicol.2014 Feb; 64:177-83) 
  
2. CHUKKU– Zingiber officinale, Rosc.  
Family : Zingiberaceae 
Useful part : Root tuber (dried) 
Organoleptic Character: 
               Taste  : Acrid  
                Potency  : Veppam 
               Division : Acrid 
Actions: Carminative, Stomachic 
General properties: 
Chukku is indicated for Vaatha diseases, sinusitis, headache. 
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         Å¡¾ô À¢½¢ÅÂ¢ ê¾ü ¦ºÅ¢Å¡ö 
              ÅÄ¢¾¨Ä ÅÄ¢Ý¨Ä ÅÄ¢Â¢Õ Å¢Æ¢¿£÷ 
          º£¾ò ¦¾¡ÎÅÃ¢ §À¾¢ô ÀÄ§Ã¡ 
              º¢¸ÁÄ¢ Ó¸Á¸ Ó¸Á¢Ê ¸ÀÁ¡÷ 
                                  - (§¾¨ÃÂ÷ Ì½Å¡¸¼õ)   
Chemical constituents: 
 It is indicated for 1-2% volatile oil, resinous matter, diarylheptanoid, gingerol, 
gingerdione, starch, mucilage, sesquiterpenes like zingiberine, bisabolene. 
 
Pharmacological activity: 
Anti-inflammatory and Analgesic activity: 
 Diarylheptanoid having catechol group showed activity against 5-Lox which further 
inhibited leukotriene biosynthesis which can produce anti-inflammatory effects. 
 Gingerol and gingerdione showed analgesic and anti-inflammatory activity by 
inhibited the prostaglandin synthesis 
Stomachic, antioxidant, anti dote. 
 Indian Herbal Pharmacopoeia, P – 48 
3. MILAGU – Piper nigrum.Linn  
Family : Piperaceae 
Useful part : Seeds 
Organoleptic Character: 
Taste  : Bitter, acrid 
Potency : Veppam  
Division : Acrid 
Actions: Antivaatha 
General properties: 
‚º£¾ÍÃõ À¡ñÎ º¢§ÄòÁí ¸¢Ã¡½¢ÌýÁõ 
 Å¡¾õ «Õº¢À¢ò¾õ Á¡ãÄõ- µÐºýÉ¢ 
 Â¡ºÁÀŠ Á¡Ãõ «¼ý§Á¸õ ¸¡ºÁ¢¨Å 
 ¿¡ºí ¸È¢Á¢Ç¸¢É¡ø.‛ 
- («¸ò¾¢Â÷ Ì½Å¡¸¼õ) 
 Milagu is indicated for anaemia, dysentery, ulcer, fever, vaatha diseases, haemorrhoids. 
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Chemical constituents: 
Oleoresin, alkaloid, volatile oil, alkaloid called piperine, amide known as pipericide. 
 
Pharmacological activity: 
Anti-inflammatory and Antipyretic activity:  
 Piperine can effectively abrofath interleukin-1B induced over expression of 
inflammatory mediators.  
 In humans piperine increases the bioavailability of antitubercular drugs. 
 Piperin possesses CNS depressant, antipyretic,anti-inflammatory,antioxidant 
                                                     -Indian Herbal Pharmacopoeia, P – 424 
 
4. THIPPILI - Piper longum  
Family                     : Piperaceae 
Useful part              : Fruit  
Organoleptic Character: 
Taste : Sweet 
Potency : Veppam                
Division : Sweet 
 Actions                   : Carminative 
General properties: 
‚ÅÕÁ Äô¦ÀÕì §¸¡Î Á§¸¡¾Ãõ 
 Å¡¾õ ¬¾¢Óò §¾¡¼ï ÍÃíÌÇÇ¢÷ 
 ¦ÀÕÁ¡¨ÄôÒÃ¢ §Á¸ô À¢¼¸Óõ 
 §ÀÕó ¾¢ôÀ¢Ä¢ô §ÀÃíÌ¨Ãì¸§Å‛ 
- (§¾¨ÃÂ÷ Ì½Å¡¸¼õ)   
Uses : 
Thippili is used for ascites, vaatham, pitham, kapham types of diseases, fever. 
 
Chemical constituents: 
Volatile oil, resin, alkaloids piperine, N-isobutyldecatrans-2-trans-4-dienamide, 
terpenoid substance, piperlongumine, piplartine.p-cymene. 
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Pharmacological activity: 
Anti-inflammatory activity and Analgesic activity: 
 Itt having anti-inflammatory and analgesic activity. 
 Antiallergic, antiasthmatic ,hepatoprotective activity 
                          Indian Herbal Pharmacopoeia, P – 315 
 Piperine increases the bioavailability of chemotherapeutic drugs.piperine as a   
supplement to chemotherapeutic drugs to enhance their bioavailability. 
            (Herbal medicine: Acancer chemopreventive and therapeutic 
perspective-effects of natural polyphenols on chemoradiotherapy in cancer) 
 
5. OMAM : Carum copticum 
Family  : Solanaceae 
Useful part  : Seeds 
Organoleptic characters: 
 Taste  : Kaarppu 
 Potency : Veppam 
 Division : Kaarppu 
General properties: 
"º£¾ÍÃí ¸¡ºï ¦ºÃ¢Â¡Áó ¾õ¦À¡ÕÁø 
 §À¾¢Â¢¨Ãî ºø¸ÎôÒ §ÀÃ¡Áõ- µ¾¢ÕÁø 
 Àø¦Ä¡ÎÀø ãÄõ À¸Á¢¨Å§¿¡ ¦Âý¦ºÔ§Á¡? 
 ¦º¡ø¦Ä¡Î §À¡õ µÁ¦ÁÉî ¦º¡ø." 
- («¸ò¾¢Â÷ Ì½Å¡¸¼õ) 
 Chemical Constituents: 
 The chemical composition of essential oil obtained from dry dry fruits of carum.  
Thymol (35-60), a-pinene, p-cymene, limonene and a-terpinene have been found.  Camphene, 
carvacrol, cvmene, dipentene, myrcne, phenols, terpinene, thymine, thymol, linoleic acid. 
      -Database, vol- VII, p-498 
Actions: 
 Carminative, Stimulant, Stomachic, Anti spasmodic, Tonic, Antimicrobial, Diuretic, 
Antispasmodic. 
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Uses: 
 A paste of the curshed fruit is applied externally for relieving pains. 
      - Database, vol- VII, p-497-498 
6. KADUGU: Brassica juncea 
Family : Brassicaceae 
Useful part : Seeds 
Organoleptic characters: 
 Taste   : kaarppu 
 Potency : veppam 
 Division : kaarppu 
General properties: 
"þÊ¸¡º ¿¡º¢Ý Ã£¨Ç¸Àõ À¢ò¾í 
 ¸ÊÅ¡¾ º£¾í ¸Îô§À¡-Î¼Ä¢ü 
 ÀÎ§¸¡ðÎ §¿¡¦ÂýÛõ Àí¸¢¨Å¸ ¨ÇôÒñ 
 ¸Î§¸¡ðÎ §ÁýÁÕóÐ ¸¡ñ." 
- («¸ò¾¢Â÷ Ì½Å¡¸¼õ) 
 
Chemical Constituents: 
 Glucosides – Sinalbin, sinargin, potassium myronate. 
Actions: 
 Emetic, Stimulant, Rubefacients, Vesicant, Digestive, Diuretic. 
Uses: 
 Powdered mustard mixed with hot water can be given for Hiccough, It is mixed with 
honey and can be given for Bronchial Asthma. 
 
7. SIRUTHEKKU: Clerodendrum serratum (linn) Moon. 
Family  : Verbenaceae 
Useful part  : Leef, Root. 
Organoleptic characters: 
 Taste  : Kaipu, Thuvarppu 
 Potency : Veppam 
 Division : kaarppu 
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General properties: 
"¸ñÎÀ¡ Ãí¸¢¦ÂÛï º¢Ú§¾¸ Ìñ§¼ø, 
  ¸¡¦Äí§¸ À¢ò¾¦Áí§¸ ¸Àó¾¡ ¦Éí§¸ 
 ¦¾¡ñÎ¦¾¡ðÎò ¦¾¡¼÷ÍÅ¡º ¸¡º ¦Áí§¸ 
  ÍÃ¦Áí§¸ ¦ÅÈ¢¦Âí§¸ ¦¾¡É¢§¿¡ ¦Âí§¸" 
- (§¾¨ÃÂ÷ Ì½Å¡¸¼õ)   
Uses: 
 Siruthekku is used for body pain, fever, vaatha disease, asthma, sinusitis. 
ACTIONS: 
 Stimulant, Sedative 
Chemical constituents: 
 Flavonoids, glycosides, saponins, sterols, D-mannitol, sitosterol 
Pharmacological activity: 
 Analgesic, anti-inflammatory, antifungal, antibacterial, antiprotozoal, anticancer and 
diuretic activities. 
     
8. YAANAITHIPPILI: Scindapsus officinalis, Schott 
Family   : Araceae 
Useful parts   : Seeds 
Organoleptic characters: 
 Taste  : kaarppu 
 Potency : veppam 
 Division : kaarppu 
Action: 
 Stomachic, Stimulant, Anthelmintic, Sudorific (diaphoretic) 
General Properties: 
Á¡¾ÁÚó ¾£ÀÉÁ¡ Á¡È¡ì ¸Àí¸ÃôÀ¡ý 
µÐÌÃü ¸õÁÄ¢¨Â §Â¡Îí¸¡ñ-â¾Äò¾¢ü 
§º¡¨É¨Â§¿÷ ¿¡º¢É£÷ §¾¡Ä¡îÍ Å¡ºÓõ§À¡õ 
Â¡¨ÉÂ¢Éü È¢ôÀ¢Ä¢Â ¾¡ø. 
        - («¸ò¾¢Â÷ Ì½Å¡¸¼õ) 
Uses: 
It is used for cough, asthma, throat pain, abdominal discomfort. 
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9. KOSTAM: Costus speciosus, (Koenig x Retz.) 
Family   : Zingiberaceae 
Useful parts    : Root tuber 
Organoleptic characters: 
 Taste    : Kaippu, Viruviruppu. 
 Potency    : Veppam 
 Division    : Kaarppu 
 Actions: 
 Anti- inflammatory, Spasmolytic, Muscle relaxant, Tonic, Stimulant. 
General properties: 
"¿¡ðÊÖÚ ¦Åð¨¼ ¿Îì¸õ ±Û§¿¡ö¸û 
 §¸¡ðð¦ÁÉî ¦º¡ýÉ¡ø Ì¨ÄÔí¸¡ñ-ÜðÊü 
 ÍÃ§¾¡¼ó ¦¾¡ñ¨¼§¿¡ö §¾¡Ä¡¾ À¢ò¾õ 
 ÀÃ§¾ºõ §À¡§Á ÀÈóÐ." 
- («¸ò¾¢Â÷ Ì½Å¡¸¼õ) 
 Uses: 
 It is indicated for fever, throat disorders and pitha diseases. 
Chemical constituents: 
 Rhizomes contains 2-4% Diosgenin. Rhizomes source of corticosteroids, sex-
hormones. 
Pharmacological activity: 
 Anti-inflammatory, spasmolytic, antivenom, anthelmintic, analgesic, antipyretic 
effects, anticancer activities. 
  
10. PERUNGAYAM: Ferula asafoetida 
 Family  : Umbelliferaceae 
Useful parts : Gum-Resins 
Organoleptic characters: 
 Taste   : Kaippu, Karakarappu. 
 Potency  : Veppam 
 Division  : Kaarppu 
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General properties: 
"¾ó¾§Å ¾ó¾ ãÄò¦¾ØõÀ¢½¢ 
  ºÕÅ¸¡ûõ Å¢Õîº¢¸í¸£¼õÁ¡ 
 Áó¾õÅ¡¾õ ¯¾¡Å÷ò¾õ «øÌø§¿¡ö 
  Á¡÷À½í¸ð¼ ÌýÁõÁ§¸¡¾Ãõ‛ 
- (§¾¨ÃÂ÷ Ì½Å¡¸¼õ)   
It is used for Gum diseases, snake poisons, scorpion poisons, vaatha diseases,              
ulcer, ascities. 
Chemical constituents: 
 Organic sulphur compound, volatile oil containing essential oil of glic- 
allyl,allylpersulphide and two terpenes, ferulic acid, ester of ssaresino- tannol, alsomail, 
acetic, formic and valerainic acids. 
Actions: 
 Stimulant, Carminative, Anti spasmodic, Anthelmintic, Emmengagogue, Expectorant, 
Nervine tonic. 
    -Indian Medicinal plants vol-III orients Longaman, P-13. 
 
 11. VASAMBU: Acorus calamus  
Family : Arecacea 
Useful parts : Rhizome 
Organoleptic characters: 
 Taste  : Karppu. 
 Potency : Veppam 
 Division : Kaarppu 
Actions: 
 Anodyne, Aphrodisiac, Aromaic, Febrifuge, sedative, Stimulant. 
 
General properties: 
"À¡õÀ¾¢ ¿ïºü Ò¾ôÒñ ÅÄ¢Å¢¼À¡¸í ÌýÁõ 
 ÝõÀ¡ Ã¢Ãò¾À¢ò ¾õÓ¸ ¿¡üÈõÅý Ý¨ÄºýÉ¢ 
 Å£õÀ¡õ¨À ¸¡ºõ À¢Ä£¸ï º¢Ä¢À¾õ Å£È¢ÕÁø 
 ¾¡õÀ¡í ¸¢ÕÁ¢ Â¢¨Å§ÂÌ Á¡º¢Å ºõÀ¢¨É§Â. 
       - (§¾¨ÃÂ÷ Ì½Å¡¸¼õ)   
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Chemical constituents: 
 Asarone, Calamenol, Calamene, Eugenol, Methyl, Eufenol, Pinene, Camphene, 
Calamol, Azulene. 
       Database Vol- I, p-471 
Action: 
 Stimulant, Stomachic, Antiperiodic Carminative, Nauseant, Emetic, Disinfectant, 
Germicide, Spasmolytic, Hypothermic, Anticonvulsant 
       -Database Vol-I, P-471 
Uses: 
 Plant causes sedative effect.  It also reduces pain (Analgesic effect) 
Phytochemicals: 
 Glucoside acorin renders the aromatic.  Acorenone, isoshyobunine, b-asarone, 
calamendiol, -selinene, a-calacorene, calamuseneone, camphone and shyobunone are the 
constituents of the essential oil of sweet flag. 
 
12. SOTRUPPU- Sodium chlorid 
   Taste  : Uvarppu 
  Potency : Veppam. 
  Division  : Kaarppu. 
General properties: 
"«Çò¾¢Ö¨È ¿øÖô ÀÉøÅ¡¾õ ÁüÚí 
 ¸ÇòÐ§¿¡ö ¾ý¨Éì ¸¨ÇÔí-¸¢¨Çò¾¸À 
 ¬Í¨¼Â Åø¨Ä§¿¡ö «‰¼ÌýÁ Óõ§À¡ìÌí 
 ¸¡º¢É¢Ôû Á¡§¾ ¸ÆÚ" 
Actions: 
Stomachic, Laxative, Emetic, Anthelmintic, Antiperiodic. 
 
13. INDHUPPU- Sodium Chloride Impura 
Taste  : Uvarppu 
Potency : Veppam. 
 Division : Kaarppu. 
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      General properties: 
‚«ð¼ÌýÁ Áó¾õ «º¢÷¸ÃïÝ÷ º£¾À¢ò¾ó 
 Ðð¼¨ÅÂõ ¿¡ÊôÒñ §¼¡¼í¸û-¦¸ð¼ÁÄì 
 ¸ðÎÅ¢¼ Å¢ó¨¾Âì ¸¡Á¢Â§É¡ö Åý¸ÃôÀ¡ý 
 Å¢ðÎÅ¢¼ Å¢óÐô¨À Å¢û‛ 
Actions:  Stomachic, Diuretic, Carminative. 
 
14. SARKARAI- Saccharum ofificinarum.Linn 
Family  : Gramineae  
Useful parts  : Root and stem juice 
Organoleptic Characters: 
 Taste  : Sweet 
Potency : Seetham                
Division : Sweet 
Actions: 
 Cooling, antiseptic, diuretic, nutrient, demulcent 
General properties: 
"º£É¢î º÷ì¸¨ÃìÌò ¾£Ã¡¾ ÅýÍÃÓí 
 ÜÉ¢ìÌõ Å¡¾ò¾¢ý ÜðÎÃÈ×õ-²É¢üÌõ 
 Å¡ó¾¢ ¦Â¡Î¸¢ÕÁ¢ Á¡È¡¾ Å¢ì¸Ö§Á 
 §À¡ó¾¢¨º¨Â Å¢ðÎô ÒÃñÎ" 
        - («¸ò¾¢Â÷ Ì½Å¡¸¼õ) 
It is used for vaatha disease, fever, vomiting, hiccough. 
 
PROPERTIES OF EXTERNAL MEDIINE 
1. VEERAM- HYDRAGYRUM PERCHLORIDE 
Taste  : Bitter 
Potency : Veppam. 
Division : Kaarppu. 
Actions: Tonic, Antiseptic and Caustic properties. 
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General properties: 
"ÌýÁ¦Á¡Î Ìð¼í ¦¸¡ÊÂÅÉ¢ Äò¾¢ÃðÎ 
 ÐýÁ¡í ¸¢ºô¦ÀÕì¸ï Ý¨Ä§¿¡ö-Åý¨ÁÔÚ 
 ¸¡Á¢ÂôÒñ ½¡¾¢Â§¿¡ö ¸ñ¼¡üºù 
 Å£Ã¦ÉÛï º¡Á¢¿¡ Áò¨¾Ôî ºÃ¢" 
Uses : Gastric ulcer, leprosy, severe vatha diseases and morbid growth of flesh, throbbing  
pain, venereal disease, eye diseases 
2. HONEY WAX 
Action : Demulcent 
Uses :  Ointment, creams, paste, plaster. 
General properties: 
"«¨ÈÀì¸ Å¡¾ Á¨¾ô¨ÀÂ ã¨¾ 
 Ì¨ÈÅ¢ó¾¢ ¾ú§¿¡ö §¾ûÜÇ¢-¸¨È¨Âô 
 ÒØ¦¸Îì¸ Åí¸ÓÚ Òñ½¢ÊÒñ ËôÒñ 
¦ÁØ¦¸Îì¸ Å¡í¸Ö ¦Áö" 
Uses :  Vaatha disease, edema, hemiplegia, scorpion poison, leprosy, wounds. 
3. COCUNUT OIL: Cocos nucifera 
Family  : Arecacea 
Useful parts  : Endosperm              
Organoleptic Characters: 
Potency :  Thatpam                     
Division : Sweet   
Actions:  Refrigerant, nutrition, demulcent,     
General properties: 
"§¾í¸¡Â¢ ¦ÉöÂ¾É¡ü Ã¢Â¡ø ÅÕÒñ§À¡õ 
 À¡í¸¡¸ì Üó¾ü À¼÷ó§¾Ú-¿£í¸¡¾ 
 ÀøÄÊÂ¢ý §É¡Ôõ À¼÷¾¡ Á¨Ãº¢ÃíÌõ 
 «øÄÈô §À¡¦Áý ÈÈ¢" 
                                   - («¸ò¾¢Â÷ Ì½Å¡¸¼õ) 
Chemical Constituents: 
 Amino acids-Arginine, alanine, lysine, histidine, tyrosine,  
 Fatty acids-Lauric acid, myristic acid. 
41 
 
INGREDIENTS OF AKKINI CHOORANAM 
 
 THIPPILI - Piper longam                                                    CHUKKU -  Zingiber officinale             
                            
 
 
 INDHUPPU-ROCK SALT                                                      MILAGU - Piper nigrum 
                   
 
 
KODIVELIVER - Plumbago zeylanica                                          KOSTAM - Costus speciosus 
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    VASAMBU- Acorus calamus                                                    KADUGU- Brassica junceae 
                    
  
 
OOMAM - Carum copticum                                                  YAANAI THIPPILI - Scindapsus officinalis 
 
                                   
 
     PERUNGAYAM - Ferula asafoetida                                    SIRUTHEAKKU- Clerodendrum serratum 
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  SOTTRUPPU- SODIUM CHLORIDE                                         SUGAR- Saccharum officinarum 
 
                               
 
 
 
INGREDIENTS OF VEERA MEZHUGU 
 
 
VEERUM- HYDRAGYRUM PERCHLORIDE                  THEAN MEZHUGU- HONEY WAX 
 
      
 
 
 
                                                  COCONUT OIL - Cocus nucifera 
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MATERIALS AND METHODS 
 
STANDARD OPERATIVE PROCEDURE 
Source of Trial Medicine: 
           The required raw drugs for the preparation of Akkini Chooranam (Internal) and Veera 
Mezhugu (External) will be purchased from a well reputed country shop and the raw drugs 
will be authenticated by the competent authority. After that the raw drugs will be purified 
separately and the Medicine is prepared in Gunapadam laboratory - National Institute of 
Siddha. 
 The herbal ingredients of the trial drug get authendicated from Dr.D.Aravind, 
Assisant Professor, Department of Medicinal Botany, National Institute of Siddha, Chennai. 
The Mineral ingredients get authenticated from Siddha Central Research Institute, Chennai. 
PREPARATION OF TRIAL DRUGS: 
A. Internal Medicine:       
Ingredients:  
· Purified Kodiveli (Plumbago zyelanica)     - 1 Palam (35 gms) 
· Thirikadugu (Zingiber officinale, Piper nigrum, Piper longum) - 1Palam (35 gms) 
· Oomam (Carum copticum)       - 1 Palam (35 gms) 
· Sirutheakku (Clerodendrum serratum)     - 1 Palam (35 gms) 
· Yaanai thippili (Scindapsus officinalis)     - 1 Palam (35 gms) 
· Kostam (Costus speciosus)       - 1 Palam (35gms) 
· Sottruppu (Sodium chloride)       - 1 Palam (35 gms) 
· Indhuppu (Sodium chloride impura rock salt)     - 1 Palam (35 gms) 
· Perungayam (Ferula asafoetida)      -  ¼Palam(8.75gms) 
· Vasambu (Acorus calamus)        -  ¼ Palam(8.75gms) 
· Kadugu (Brassica juncea)       -  ½ Palam(17.5gms) 
· Sarkarai (Sugar)         -  9Palam(315 gms)  
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Purification of Raw Drugs: 
Kodiveli:  
Inner nerve of the root is removed, then the outer part is dried and make into powder. 
The powder is taken in a broad mouthed vessel containing cow‟s milk, closed with another 
broad mouthed vessel, subjected to heat for three hours. Finally the product is finely 
powdered in a Kalvam and taken. 
Chukku:  
Soak in lime stone water for 1 Saamam (3 hours) and dry it in shade then peel off the 
outer layer.                                                                                             
 Milagu: 
Soak in butter milk for 1 Saamam (3 hours) then allow it to dry.                                                                     
 
       
Thippili:  
 Soak in  juice  of  Lime  for  a  period  of time   then  allow it  to  dry.  
 
 
Omam:  
Soak in lime stone water then dry it.    
 
 
Siruthekku:  
Outer  layer  is  peeled  off  made  into   small  pieces  then  dried  in  sunlight.                                                                   
 
 
Yaanai Thippili:  
Soak in kaadi for a period of 1 saamam (3 hours) then dry it in sunlight.                            
Kostum:  
Remove Unwanted dust and stones dry it in sunlight. 
Sottruppu:  
Soak in butter milk and then dry it in sunlight. 
Indhuppu:  
Soak  in  kaadi   for  a  period  of  3days  then  dry  it  in  sunlight. 
Perungayam:  
Fried in an mud vessel. 
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Vasambu:  
Exposed to flame until it becomes coal. 
Kadugu:  
Remove  unwanted  dust  and  stones,  dry  it  for  2 days  in  sunlight. 
Method of preparation: 
 The purified Kodiveli, Thirikadugu, Omam, Sirutheku, Yaanaithippili, Kostam were 
fried still it becomes golden colour then they were powdered and sieved by a cloth.  The 
sottruppu and indhuppu were made it into fine powder in a culvam. The the purified 
Perungayam and Vasambu were also powdered separately. 
           The above powders were mixed together along with Kadugu powder and equal amount 
of sugar is added to the total amount of all the above mentioned drugs and mixed thoroughly. 
Then it was stored in a clean container. 
B. External Medicine: 
Ingredients: 
 Veeram (Hydragyrum per chloride)   - 1Thola (12gram) 
 Then mezhugu (Honey wax)             - 1Palam (35gram)  
 Thengai ennai (Coconut oil)  - Q.S. 
Purification of drug:   
Veeram:  
 Take veeram in a container and put cow‟s milk above the level of veeram fully 
merged and dry in a sun light. 
 Method of preparation: 
  First veeram should be powdered in a kalvam. Take a vessel and put honey wax on 
that, heated for sometimes after getting melted, above veeram powder and coconut oil should 
be mixed and make it into a paste and stored in a clean container. 
Drug storage:     
The trial drug Akkini chooranam is stored in clean and dry container and Veera 
mezhugu is stored in clean and dry bottles. 
Dispensing: 
        The Chooranam is given in packets and Mezhugu is given in Ziplock covers. 
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TRIAL DRUGS 
 
AKKINI CHOORANAM: 
 
 
 
VEERA MEZHUGU: 
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CHEMICAL EVALUATION 
Experimental procedure:  
5gms of Akkini Chooranam was taken in a 250 ml of clean beaker and 50ml of 
distilled water was added to it. Then it was boiled well for about 10 min. Then it is allowed to 
cool and filtered in a 100 ml volumetric flask and made up to 100 ml with distilled water. 
This preparation is used for the qualitative analysis of acidic/ basic radicals and biochemical 
constituents in it. 
Preparation of extract:  
5gm of Akkini Chooranamis weighed accurately and placed in a 250ml clean beaker 
and 50ml of distilled water was added with it. Then it was boiled well for about 10 minutes. 
Then it was allowed to cool and filtered in a 100ml volumetric flask and made up to 100ml 
with distilled water. The chemical analysis of Akkini Chooranam was done at Biochemistry 
lab, National Institute of siddha, Chennai-47. 
Preliminary test for Copper, Sodium, Silicate and Carbonate: 
 Test for Silicate: 
a. A little (500mg) of the sample is shaken well with distilled water. 
b. A little (500mg) of the sample is shaken well with con. HCl/Con. H2So4. 
 Action of Heat: A small amount (500mg) of the sample is taken in a dry test tube 
and heated gently at first and then strong. 
 Action of Heat: A small amount (500mg) of the sample is taken in a dry test tube 
and heated gently at first and then strong. 
 Flame Test: A small amount (500mg) of the sample is made into a paste with con. 
HCl in a watch glass and introduced into non-luminous part of the Bunsen flame. 
 Ash Test: A filter paper is soaked into a mixture of sample and dil. cobalt nitrate 
solution and introduced into the Bunsen flame and ignited. 
Test For Acid Radicals 
 Test For Sulphate: 2ml of the above prepared extract was taken in a test tube and 
2ml of 4% dil. ammonium oxalate solution was added. 
 Test For Chloride: 2ml of the above prepared extracts was added with 2ml of dil-
HNO3 until the effervescence ceases off. Then 2 ml of silver nitrate solution was 
added. 
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 Test For Phosphate: 2ml of the extract was treated with 2ml of con.HNo3 and 2ml 
of dil. ammonium molybdate solution.   
 Test For Carbonate: 2ml of the extract was treated with 2ml dil. magnesium 
sulphate solution 
 Test For Nitrate: 1gm of the substance was heated with copper turning and 
concentrated H2SO4 and viewed the test tube vertically down. 
 Test For Sulphide: 1gm of the substance was treated with 2ml of con. HCL 
 Test For Fluoride & Oxalate: 2ml of extract was added with 2ml of dil. Acetic 
acid and 2ml dil.calcium chloride solution and heated. 
 Test For Nitrite: 3drops of the extract was placed on a filter paper, on that-2 drops 
of dil.acetic acid and 2 drops of dil. Benzidine solution were placed. 
Test For Basic Radicals 
 Test For Lead: 2ml of the extract was added with 2ml of dil. potassium iodine 
solution. 
 Test For Copper: One pinch (50mg) of substance was made into paste with con. HCl 
in a watch glass and introduced into the non-luminous part of the flame. 
 Test For Aluminium: In the 2ml of extract dil. sodium hydroxide was added in 5 
drops to excess. 
 Test For Iron: 
 To the 2ml of extract add 2ml of dil. ammonium solution 
 To the 2ml of extract 2ml  thiocyanate solution and 2ml  of con HNo3 is        
          added. 
 Test For Zinc: In 2ml of the extract dil.sodium hydroxide solution was added in 5 
drops to excess and dil.ammonium chloride was added.  
 Test For Calcium: 2ml of the extract was added with 2ml of 4% dil.ammonium 
oxalate solution  
 Test For Magnesium: In 2ml of extract dil.sodium hydroxide solution was added in 
drops toexcess. 
 Test For Ammonium: In 2ml of extract 1 ml of Nessler's reagent and excess of dil. 
sodium hydroxide solution were added. 
 Test For Potassium: A pinch (25mg) of substance  was treated  with 2ml of dil. 
sodium nitrite solution and then treated with 2ml of dil. cobalt nitrate in 30% dil. 
glacial acetic acid. 
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 Test For Sodium: 2 pinches (50mg) of the substance was made into paste by using 
HCl and introduced into the blue flame of Bunsen burner. 
 Test For Mercury: 2ml of the extract was treated with 2ml of dil. sodium 
hydroxide solution.  
 Test For Arsenic: 2ml of the extract was treated with 2ml of dil. sodium hydroxide 
solution. 
Other constituents 
 Test For Starch : 2ml of extract was treated with weak dil. iodine solution  
 Test For Reducing Sugar: 5ml of Benedict's qualitative solution was taken in a test 
tube and allowed to boil for 2 minutes and added 8 to 10 drops of the extract and 
again boil it for 2 minutes.  
 Test For The Alkaloids: 
 2ml of the extract is treated with 2ml of dil. potassium iodide solution.    
 2ml of the extract is treated with 2ml of dil. picric acid. 
 Test For Tannic Acid: 2ml of extract was treated with 2ml of dil. ferric chloride 
solution 
 Test For Unsaturated Compound: In the 2ml of extract 2ml of dil. Potassium 
permanganate solution was added.  
 Test For Amino Acid: 2 drops of the extract was placed on a filter paper and dried 
well, and then 20ml of Burette reagent was added in it. 
CLINICAL STUDY: 
STUDY DESIGN: 
      An open clinical trial 
STUDY PLACE:  
Ayothidoss Pandithar Hospital, National Institute of Siddha, Tambaram sanatorium, 
Chennai-47.  
STUDY PERIOD :  18 months 
SAMPLE SIZE    :   40 patients          
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SUBJECT SELECTION: 
             Patients reporting with symptoms of Kuthikaal vaatham will be subjected to 
screening using screening Proforma. Then they will be allowed for the study fulfilling the 
following criteria. 
INCLUSION CRITERIA:  
 Age : 20 - 60 Yrs 
 Sex : Both male and female 
 Pain and tenderness in the sole of the foot while on walking and standing. 
 Heel Pain gets worse when getting up in the morning. 
 Patients willing to undergo radiological investigation and Laboratory 
investigations. 
 Patients willing to sign the informed consent. 
EXCLUSION CRITERIA: 
 H/o Cardiac diseases 
 H/o Diabetes mellitus 
 H/o Rheumatoid arthritis 
 H/o Chronic kidney disease   
 Pregnancy and lactation      
 Septic arthritis        
 Gonococcal arthritis  
 Psoriatic arthritis 
 Patient with any other serious systemic illness.  
WITHDRAWAL CRITERIA: 
 Intolerance to the drug and development of adverse reactions during drug trial. 
 Poor patient compliance and defaulters. 
 Patient turning unwilling to continue in the course of clinical trial. 
 Occurrence of any serious illness 
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TESTS AND ASSESSMENTS: 
A. Clinical assessment  
B. Laboratory investigations 
C. Radiological investigations 
D.  Siddha system assessment 
A.CLINICAL ASSESSMENT: 
 Pain  
 Swelling  
 Stiffness  
 Tenderness 
 Warmth 
 Restricted movements. 
B. Routine investigation: 
Blood: 
 Hb 
 Total WBC Count 
 DC-  Polymorphs 
1. Lymphocytes  
2. Eosinophil  
3. Monocytes  
4. Basophils  
 Total RBC count 
 ESR 
½ Hr:                 1 Hr: 
 Blood sugar 
Fasting:               PP: 
      Urine: 
 Albumin 
 Sugar 
 Deposits 
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Renal function tests: 
 Urea 
 Creatinine 
Liver function tests: 
 Serum total bilirubin 
 Direct bilirubin 
 Indirect bilirubin 
 Serum Alkaline phosphatases 
 SGOT 
 SGPT         
C. SPECIFIC INVESTIGATIONS: 
 CRP 
 ASO TITRE 
 RA FACTOR  
D. RADIOLOGICAL INVESTIGATIONS 
 X- Ray Heel (AP and Lat view) 
E. SIDDHA PARAMETERS: 
     Envagai thervugal: 
 Naadi 
 Sparisam 
 Naa 
 Niram 
 Mozhi 
 Vizhi 
 Malam 
 Moothiram 
 Neerkkuri 
 Neikkuri 
DATA COLLECTION FORMS: 
 Required information will be collected from each patient by using the following 
forms: 
FORMS:  
 Form I    Screening and selection Proforma  
 Form II    History taking & Clinical assessment Proforma  
 Form III    Laboratory investigation Proforma  
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 Form IV  Drug compliance form 
 Form V  Patient information sheet 
 Form VI  Consent form 
 Form VII  Withdrawal form  
 Form VIII  Dietary Advice form 
 Form  IX                   Pharmacovigilance form  
STUDY ENROLLMENT:  
Patients reporting at the OPD with the clinical symptoms of Kuthikaal vaatham, 
examined clinically for enrolling in the study based on the inclusion and exclusion criteria.  
The patients who were enrolled would be informed (Form VI) about the study, trial 
drug, possible outcomes and the objectives of the study in the language and terms 
understandable to them and informed consent were obtained in writing from them in the 
consent form (Form VI). All these patients were given unique registration card in which 
patients Registration number of the study, Address, Phone number and Doctors phone 
number etc. were given to report easily for any complications arises. 
Complete clinical history, complaints and duration, examination findings and 
laboratory investigations -- would be recorded in the prescribed Proforma.  Patients were 
advised to take the trial drug and to follow the appropriate dietary advice. 
CONDUCT OF THE STUDY: 
Purgation with Meganaatha Kuligai-2pills with Hot water at early morning in empty 
stomach was given for balancing the deranged mukkutram a day before the treatment.  
The trial drugs Akkini chooranam (Internal) and Veera mezhugu (External) given 
continuously for 48 days.  Patients were requested to visit the hospital OPD once in seven 
days for this study. The severe cases (patients unable to walk) were admitted in the IPD and 
progress assessed daily. In every visit the clinical assessment done and prognosis noted in the 
Prescribed Proformas in the presence of Faculty members of Dept. of Sirappu Maruthuvam. 
Laboratory investigations and Radiological investigation was done before and last day of the 
trial.  Defaulters were not allowed to continue and withdrawn from the study.  
 
 
 
56 
 
DATA ANALYSIS: 
 After enrolling the patient for the study, a separate file for each patient and all forms 
were kept in the file.  Study No. and Patient No. were written on the top of file for easy 
identification.  Whenever the patient visits OPD during the study period, the respective 
patient‟s file taken and necessary entries were made at the assessment form or other suitable 
form.  The screening forms were filed separately.  The data recordings were monitored for 
completion and adverse event by HOD and pharmacovigilance committee.  All forms were 
further scrutinized in presence of Investigators by Sr. Research Officer (Statistics) for logical 
errors and incompleteness of data to avoid any bias. 
ADVERSE EFFECT/SERIOUS EFFECT MANAGEMENT 
If the trial patient develops any adverse reaction, he/she would be immediately 
withdrawn from the trial and proper management was given in OPD of National Institute of 
Siddha and the same informed to the Pharmaco-vigilance committee of NIS. 
OUTCOME: 
Primary outcome: 
 Primary outcome of the study is pain relieving and it will be assessed by the following 
methods:  
      1. Universal Pain assessment scale (before and after treatment) 
      2. Restricted movement assessment scale (before and after treatment) 
1. UNIVERSAL PAIN ASSESMENT SCALE: 
  
            Grade 0    :   No Pain 
 Grade 1-3 :   Mild pain 
 Grade 4-6 :   Moderate pain 
 Grade 7-10 :   Severe pain 
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The improvement is assessed by pain scale method. They are 
Grade 0 - Good Improvement 
Grade 1-3 - Moderate Improvement 
Grade 4-6 - Mild Improvement 
Grade 7-10 - No Improvement Improvement 
2. RESTRICTED MOVEMENT ASSESSMENT SCALE: 
GRADATION OF MOVEMENTS 
 
 GRADE I        - Fit for all activities. Can do their work without support 
 GRADE II      - Mild restriction of movements, Mild pain present in Heel. 
 GRAD III       - Moderate restriction of movements, Stiffness, Pain in Heel 
           GRADE IV    - Bed ridden/ confined to chair, Severe pain.                                  
(Communication-technology society. http://pectlab dev.spcomm.uiuc.edu/drupal/ 
(submitted by DIMO 17 on wed, 03/09/2011)  
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OBSERVATION AND 
RESULTS 
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RESULTS OF CHEMICAL ANALYSIS  
QUALITATIVE ANALYSIS 
PHYSICO-CHEMICAL ANALYSIS 
Table-1: Colour, nature of Akkini Chooranam 
 
Table-2: Test for Basic radicals 
S.no Procedures Akkini Chooranam 
 
1. Test for Ammonium  
- 
2. Test for Sodium - 
 
3. Test for Magnesium - 
 
4. Test for Aluminium - 
 
5. Test for Potassium + 
 
6. Test for Calcium + 
 
7. Test for Ferrous iron  
+ 
8. Test for Copper  
- 
9. Test for Zinc  
- 
10. Test for Arsenic - 
 
11. Test for Mercury - 
 
12. Test for Lead - 
 
 
Inference 
Bio-chemical analysis for basic radicals reveals that Akkini Chooranam contains 
Potassium, Calcium and Iron. 
S.no Parameters Results Method of Testing 
 
1. Colour Brown By visual 
 
2. Odour Odour(Omam Smell) Olfactory examination 
 
 
3. Solublity  Soluble in honey 
 Soluble in water 
Qualitative 
 
 
4. Nature Powder By visual 
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Table-3: Test for Acidic radicals 
 
S.no Procedures Akkini Chooranam 
1. Test for Sulphate + 
 
2. Test for Chloride + 
 
3. Test for Phosphate + 
 
4. Test for 
Flouride&Oxalate 
 
- 
5. Test for Nitrate _ 
 
 
Table-4: Test for Acidic radicals 
 
S.no Procedures Akkini Chooranam 
 
1. Test for Starch + 
 
2. Test for Reducing sugar + 
 
3. Test for Alkaloids + 
 
4. Test for Amino acids _ 
 
5. Test for Tannic acids + 
 
6. Test for type of compounds No Change 
 
 
Inference 
 Bio-chemical analysis for acid radicals reveals that Akkini Chooranam contains 
Sulphate, Chloride, Starch, reducing sugar, Alkaloids, Tannic acids 
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CLINICAL STUDY 
 
OBSERVATIONS AND RESULTS 
Results and observations were studied and tabulated under the following heading. 
1. Age distribution 
2. Sex distribution 
3. Occupational status 
4. Diet habits 
5. Thinai reference 
6. Paruva kaalam (Seasonal changes) 
7. Socioeconomic status 
8. Yakkai ilakkanam (Physical Constitution) 
9. Gunam 
10. Duration of illness 
11. Clinical features 
12. BMI 
13. Distribution of Vaatham 
14. Distribution of Pitham 
15. Distribution of kabam 
16. Udal Thaathukkal 
17. Envagaithervu 
18. Neikkuri 
19. Outcome 
20. Results  
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1. AGE INCIDENCE:  
Table: 1. Distribution of age 
 
AGE(YEARS) NUMBERR OF CASES PERCENTAGE 
20-30 05 12.5 % 
31-40 13 32.5% 
41-50 14 35% 
51-60 08 20% 
TOTAL 40 100% 
 
Fig.No: 1 
 
 
Observation  
 
       In my study, the incidence of disease is more in the Age group between 41-50 years of 
age. 
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2. SEX DISTRIBUTION  
Table 2: 
GENDER NUMBER OF CASES PERCENTAGE 
MALE 6 15% 
FEMALE 34 85% 
TOTAL 40 100% 
 
Fig no: 2 
 
 
Observation 
 
         In this study among 40 patients Female was 85% and Male was 15%. Female was more 
affected than male was noted in my study. 
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3.  OCCUPATIONAL DISTRIBUTION 
Table 3: 
OCCUPATION NO. OF CASES PERCENTAGE 
                    House wife  
 
16 40% 
Teacher 2 5% 
Coolie 10 25% 
Security 2 5% 
Clerical 10 25% 
Total 40 100% 
 
  Fig no: 3 
 
 
 
Observation: 
          Among the 40 patients recruited, the prevalence were more in Housewives 16 (40%), 2 
(5%) were in Teacher,10 (25%) were in Coolie , 2 (5%) in Security, 10 (25%) Were  in 
clerical. 
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4. DIET HABIT 
Table: 4 
DIET HABIT NUMBER OF 
CASES 
PERCENTAGE 
Vegetarian 4 10% 
Non-Vegetarian 36 90% 
Total 40 100% 
 
Fig no: 4 
 
 
Observation: 
 Among the 40 cases recruited,the prevalence of the disease seems to higher in Non 
vegetarian 36(90%)cases than in Vegetarian 4(10%) cases. 
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5. THINAI 
Table: 5 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig no: 5 
 
 
 
 
Observation: 
           Among the 40 patients recruited, 38 (95%) cases belong to Neithal thinai, 2 (5%) cases 
belongs to Marutham. 
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100% 
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6. PARUVA KAALAM (SEASON) 
Table 6:  
 
Fig no: 6 
 
 
 
 
Observation: 
            Among the 40 patients, 16 (40%) were recruited in   koothir kaalam, 18 (45%)  in 
munpanikalam,2  (5%) in kaarkaalam & 4 (10%) cases in pinpani kaalam. 
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Kaarkaalam      (Aug 16 – Oct 15)                     
) 
2 5% 
Koothirkaalam    ( Oct 16 – Dec 15) 16 40% 
Munpanikaalam  (Dec 16 – Feb 15) 18 45% 
Pinpanikaalam    (Feb 16 – Apr 15) 4 10% 
Ilavenilkalam    (Apr 16 – Jun 15) 0 0% 
Mudhuvenil (Jun 16 –August) 15) 0 0% 
Total 40 100% 
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7. SOCIO-ECONOMIC STATUS 
Table 7:  
 
SOCIO-ECONOMIC STATUS     
NUMBER OF 
CASES 
 
PERCENTAGE 
Poor 10 25% 
Middle Class 25 62.5% 
Rich 5 12.5% 
 Total 40 100% 
 
Fig no: 7 
 
 
 
Observation: 
        Among the 40 patients recruited, 25 (63%) cases belong to Middle class, 10 cases (25%) 
belong to Poor status and 5 (12.5%) cases belong to rich status. 
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8. YAAKKAI ILAKKANAM (PHYSICAL CONSTITUTION) 
Table: 8 
 
CONSTITUTION OF THE 
BODY 
 
NUMBER OF CASES 
 
PERCENTAGE 
 
Vaatha Udal 
 
0 
 
0% 
 
Pitha Udal 
 
0 
 
0% 
 
Kaba Udal 
 
0 
 
0% 
 
Thontha Udal 
 
40 
 
100% 
 
Fig no: 8 
 
 
 
 
Observation: 
          Among the 40 (100%) patients recruited, all of them were belongs to Thontha Udal.  
 
 
 
 
 
 
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
0% 0%
0%
100%
YAAKKAI  ILAKKANAM
70 
 
9. GUNAM 
Table 9 
GUNAM NUMBER OF CASES PERCENTAGE 
SATHUVA GUNAM 0 0% 
RASATHA GUNAM 40 100% 
THAMO GUNAM 0 0% 
TOTAL 40 100% 
 
Fig no: 9 
 
 
 
Observation: 
                All the 40 patients were under Rasatha gunam. 
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10. DURATION OF ILLNESS: 
Table: 10 
DURATION OF ILLNESS NO.OF CASES PERCENTAGE 
1-6 Month 24 60% 
7month- 1year 11 27.5% 
1-2 Years 3 7.5% 
2-5 Years 2 5% 
More Than 5 Years 0 0% 
 
Fig no: 10 
 
 
 
 
 
Observation: 
 Among the 40 patients, 60% of cases had 1-6 month of illness, 27.5% of cases had 7 
months- 1 year, 7.5% of cases had 1-2 years, and 5% of cases had 2-5 years of illness. 
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11. CLINICAL FEATURES 
Table 11 
CLINICAL FEATURES NUMBER  OF 
PATIENTS 
PERCENTAGE 
% 
Pain in heel region 40 100% 
Early morning pain 40 100% 
Tenderness 35 87.5% 
Stiffness  12 30% 
Exacerbation of  pain on movements 37 92.5% 
 
    Fig no: 11 
 
 
Observation: 
              Among the 40 cases, all of them (100%) had Heel pain and early morning pain in 
heel region, 35 (87.5%) cases had diffuse tenderness with limitation of movements, 12 (30%) 
cases had stiffness and 37 (92.5%) cases had exacerbation of pain on movements. 
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12. BMI  
TABLE No: 12  
BMI Number of Cases            Percentage  
Under weight (below 18.5) 0 0% 
Normal range (18.5-24.99) 20 50% 
Over weight (25-29.99) 12 30% 
Obese (30-40) 8 20% 
Total  40 100% 
 
Fig no: 12 
                                       
 
 
 
OBSERVATIONS  
Among the 40 patients, 20 (50%) cases were in normal weight, 12 (30%) cases were 
in overweight and 8 (20%) cases in obese condition. 
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13.  DISTRIBUTION OF VAATHAM 
Table 13 
VATHAM 
NUMBER OF  
PATIENTS 
PERCENTAGE % 
Abanan 4 10% 
Viyaanan 40 100% 
Samaanan 40 100% 
Devathatan 8 20% 
 
Fig no: 13 
 
 
Observation: 
Among the observed 40 cases, Viyaanan and Samanan were affected in almost all the 
cases (100%) while Abanan was affected in 4 cases (10%) and Devathatan in 8 cases (20%).  
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14. DISTRIBUTION OF PITHAM 
Table 14 
PITHAM NUMBER OF  PATIENTS PERCENTAGE % 
Analagam 0 0% 
Ranjagam 3 7.5% 
Saathagam 40 100% 
Aalosagam 0 0% 
piragaasam 0 0% 
 
                                                    Fig No: 14         
 
 
Observation: 
              Among the 40 cases, Saathagam was affected in almost all the cases and 
Ranjagam was affected in 3cases (7.5%). 
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15. DISTRIBUTION OF KABAM 
Table 15: 
KABAM NUMBER OF  PATIENTS PERCENTAGE % 
Avalapagam 40 100% 
klaethagam 0 0% 
Pothagam 0 0% 
Tharpagam 0 0% 
Santhigam 40 100% 
 
                                                     Fig no: 15            
 
 
Observation:  
              Avalambagam and Santhigam were affected in all the 40 cases. 
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16.  UDAL THAATHUKKAL 
Table: 16 
UDAL THAATHUKKAL 
NUMBER OF  
PATIENTS PERCENTAGE % 
Saaram 40 100% 
Senneer 4 10% 
Oon 10 25% 
Kozhuppu 37 92.5% 
Enbu 40 100% 
Moolai 0 0% 
sukilam/ suronitham 0 0% 
 
                                                      Fig no: 16           
 
 
Observation: 
            Saaram and Enbu were affected in all the 40 cases (100%), Senneer was affected in 4 
cases (10%), Oon was affected in cases10 (25%), Kozhuppu was affected in 37 cases 
(92.5%), moolai and sukilam/suronitham was not affected in all the cases. 
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17. ENVAGAI THERVUGAL (EIGHT DIAGNOSTIC METHODS) 
Table 17 
ENVAGAI THERVUGAL NUMBER OF 
CASES 
PERCENTAGE 
Naadi: Vathapitha naadi 
           Pithavatham naadi 
            Pithakabam naadi 
           Kabapitham 
22 
8 
2 
8 
55% 
20% 
5% 
20% 
Naa 0 0% 
Niram 0 0% 
Mozhi 0 0% 
Vizhi 0 0% 
Sparisam 0 0% 
Malam 4 10% 
 
Observation: 
                Among the 40 patients recruited, Vaathapitha naadi was found in 22 cases (55%), 
Pithavaatha naadi was found in 8 cases (20%), Pithakaba naadi was found in 2 cases (5%), 
Kabapitha naadi was found in 8 cases (20%). Malam was affected in 4(10%) of the cases due 
to constipation.  
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18. NEIKKURI 
Table 18 
SPREADING PATTERN 
 
 
 
DING PATTERN 
NUMBER OF  
PATIENTS 
PERCENTAGE 
% 
Aravena neendathu – Vaatha neer 18 45% 
Aazhi pol paraviyadhu – Piththa neer 12 30% 
Muthothu nindrathu – Kaba neer 10 25% 
Total 40 100% 
 
    Fig no: 18  
 
 
Observation: 
Among 40 cases, Vaatha  neer was found in 18 cases (45%), Pitha neer was found in 
10 cases (25%)  and Kaba neer was found in 12cases (30%).  
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19. OUTCOME BASED ON UNIVERSAL PAIN ASSESSMENT SCALE  
S.NO OP/IP NO NAME AGE/
SEX 
BT AT RESULT 
1 H88414 Mrs.Chitra 43/F 7 0 GOOD 
2 G60332 Mr. Prakash 41/M 7 0 GOOD 
3 I3240 Mrs.Selvi 42/F 5 0 GOOD 
4 H96706 Mrs.Madhavi 50/F 10 8 NO IMPROVEMENT 
5 I6186 Mrs.Kumari 56/F 10 4 MILD 
6 I7514 Mr.Srinivasan 53/M 8 1 GOOD 
7 I8998 Mrs.Shyamala 
gowri 
38/F 10 3 MODERATE 
8 I9177 Mrs.Amsavalli 38/F 8 1 GOOD 
9 H43605 Mrs.Rajeshwari 34/F 6 0 GOOD 
10 I16170 Mrs.Kavitha 41/F 8 1 GOOD 
11 I14042 Mrs.Amutha 40/F 8 3 MODERATE 
12 I22127 Mr.Devaraj 30/M 7 0 GOOD 
13 H88529 Mrs.S.Sudha 30/F 9 3 MODERATE 
14 I7243 Mrs.Geetha 33/F 8 3 MODERATE 
15 I25806 Mr.Lindo 23/F 6 0 GOOD 
16 I27407 Mrs.Nazeera 40/F 9 5 MILD 
17 I33890 Mrs.Mahalakshmi 36/F 7 1 GOOD 
18 I13101 Mrs.Kasthuri 27/F 8 0 GOOD 
19 H91313 Mr.Elumalai 46/M 6 0 GOOD 
20 I37733 Mr.Velmurugan 54/M 7 1 GOOD 
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OUTCOME BASED ON UNIVERSAL PAIN ASSESSMENT SCALE  
S.NO OP/IP NO NAME AGE/
SEX 
BT AT RESULT 
21 IP8546 Mrs.Shanthi 43/F 7 3 MODERATE 
22 I38893 Mrs.Salmabeevi 57/F 4 0 GOOD 
23 I20360 Mrs.Malarvizhi 50/F 5 0 GOOD 
24 H69278 Mrs.Vijaya 44/F 7 0 GOOD 
25 IP8576 Mrs.Chandra 54/F 8 2 MODERATE 
26 I53175 Mrs.Padma 36/F 5 0 GOOD 
27 I48839 Mrs.Bharathi 54/F 5 0 GOOD 
28 I45309 Mrs.S.Sudha 45/F 8 1 GOOD 
29 I20358 Mrs.Srividhya 45/F 7 0 GOOD 
30 I41992 Mrs.Yasodha 37/F 7 0 GOOD 
31 I48370 Mrs.B.Shanthi 54/F 9 9 NO IMPROVEMENT 
32 I59044 Mrs.Kalaivani 45/F 7 1 GOOD 
33 I58557 Mrs.Parameshwar
i 
36/F 7 4 MILD 
34 I58557 Mrs.Manjula 43/F 9 6 MILD 
35 I59041 Mrs.Poonguzhali 34/F 6 1 GOOD 
36 I52794 Mrs.Sundari 40/F 7 0 GOOD 
37 I60014 Mrs.Srimathi 48/F 7 1 GOOD 
38 G85168 Mrs.Gajalakshmi 30/F 7 1 GOOD 
39 I65089 Mrs.Narmadha 53/F 10 9 NO IMPROVEMENT 
40 I49734 Mrs.Sasikala 43/F 6 0 GOOD 
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19. A. UNIVERSAL PAIN ASSESSMENT SCALE SCORE 
 
 
 
Observation:  
             Among the 40 cases, after the treatment the pain was reduced in 27cases (67.5%), 
mild pain was present in 6 cases (15%), moderate pain was present in 4 cases (10%) and 
severe pain was present in 3 cases (7.5%).  
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patients 
Percentage % 
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patients 
Percentage % 
No pain 0 
 
0 0% 27 67.5% 
Mild ( 1-3 ) 
 
4 10% 6               15% 
Moderate ( 4-6 ) 
 
11 27.5% 4               10% 
% Severe ( 7-10 ) 
 
25 62.5% 3               7.5% 
Total 
 
40 100% 40 100% 
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19. B. RESTRICTED MOVEMENT ASSESSMENT – GRADATION OF 
MOVEMENTS 
 
S.NO OP/IP NO NAME AGE/SEX BEFORE 
TREATMENT 
AFTER 
TREATMENT 
1 H88414 Mrs.Chitra 43/F G3 G1 
2 G60332 Mr. Prakash 41/M G3 G1 
3 I3240 Mrs.Selvi 42/F G3 G1 
4 H96706 Mrs.Madhavi 50/F G3 G3 
5 I6186 Mrs.Kumari 56/F G3 G2 
6 I7514 Mr.Srinivasan 53/M G3 G1 
7 I8998 Mrs.Shyamala gowri 38/F G3 G2 
8 I9177 Mrs.Amsavalli 38/F G3 G1 
9 H43605 Mrs.Rajeshwari 34/F G3 G1 
10 I16170 Mrs.Kavitha 41/F G3 G1 
11 I14042 Mrs.Amutha 40/F G3 G2 
12 I22127 Mr.Devaraj 30/M G3 G1 
13 H88529 Mrs.S.Sudha 30/F G3 G2 
14 I7243 Mrs.Geetha 33/F G3 G2 
15 I25806 Mr.Lindo 23/F G3 G1 
16 I27407 Mrs.Nazeera 40/F G3 G2 
17 I33890 Mrs.Mahalakshmi 36/F G3 G1 
18 I13101 Mrs.Kasthuri 27/F G3 G1 
19 H91313 Mr.Elumalai 46/M G3 G1 
20 I37733 Mr.Velmurugan 54/M G3 G1 
21 IP8546 Mrs.Shanthi 43/F G3 G2 
22 I38893 Mrs.Salmabeevi 57/F G3 G1 
23 I20360 Mrs.Malarvizhi 50/F G3 G1 
24 H69278 Mrs.Vijaya 44/F G3 G1 
25 IP8576 Mrs.Chandra 54/F G3 G2 
26 I53175 Mrs.Padma 36/F G3 G1 
27 I48839 Mrs.Bharathi 54/F G3 G1 
28 I45309 Mrs.S.Sudha 45/F G3 G1 
29 I20358 Mrs.Srividhya 45/F G3 G1 
30 I41992 Mrs.Yasodha 37/F G3 G1 
31 I48370 Mrs.B.Shanthi 54/F G3 G3 
32 I59044 Mrs.Kalaivani 45/F G3 G1 
33 I58557 Mrs.Parameshwari 36/F G3 G2 
34 I58557 Mrs.Manjula 43/F G3 G3 
35 I59041 Mrs.Poonguzhali 34/F G3 G1 
36 I52794 Mrs.Sundari 40/F G3 G1 
37 I60014 Mrs.Srimathi 48/F G3 G1 
38 G85168 Mrs.Gajalakshmi 30/F G3 G1 
39 I65089 Mrs.Narmadha 53/F G3 G3 
40 I49734 Mrs.Sasikala 43/F G3 G1 
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19. B.  RESTRICTED MOVEMENT ASSESSMENT GRADE 
 
 
 
 
 
Observation: 
 Among 40 patients, 27 (67.5%) patients were reported good relief in 
restriction of movements, 9 (22.5%) patients were reported moderate relief and restriction of 
movements continued in remaining 4 (10%) of cases. 
 
 
 
 
 
 
 
 
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
GRADE I GRADEII GRADE III GRADE IV
100.%
67.50%
22.5%
10%
BEFORE TREATMENT
AFTER TREATMENT
 
GRADING 
 
BEFORE  TREATMENT AFTER TREATMENT 
Number of 
patients 
Percentage 
% 
Number of 
patients 
Percentage 
% 
GRADE I           0 0% 27 67.5% 
GRADE II 0 0% 9 22.5% 
GRADE  III 40 100% 4 10% 
GRADE  IV 0 0% 0 0% 
TOTAL 40 100% 40 100% 
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20. RESULTS 
 The trial drug Akkini Chooarnam (internal) and Veera mezhugu (external) were 
given to 40 patients for 48 days.  
 
RESULTS 
 
NO OF CASES PERCENTAGE 
 
Good improvement 
 
 
27 
 
67.5% 
 
Moderate improvement  
 
 
6 
 
15% 
 
Mild improvement 
 
 
4 
 
10% 
 
No improvement 
 
 
3 
 
7.5% 
 
 
 
Observation:  
 The trial drug Akkini chooranam (internal) and Veera mezhugu (external) were 
given to 40 patients 48 days. Good improvement were observed in 67.50% of cases, 
Moderate improvement in 15% of cases, Mild improvement were observed in 10% of cases 
and no improvement were observed in 7.50% of cases.  
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INVESTIGATION  
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  LABORATORY INVESTIGATION OP AND IP- BEFORE AND AFTER 
TREATMENT 
 Hb(gm/dl) TOTAL 
RBC 
COUNT 
(million/c
u.mm) 
ESR 
(mm/hour
) 
TOTAL WBC 
COUNT 
S.N
O 
IP/OP 
NO 
 NAME AGE/ 
SEX 
BT AT BT AT BT AT BT AT 
1 H88414 Mrs.Chitra 43/F 12.5 13 3.8 3.8 10 8 6100 6000 
2 G60332 Mr. Prakash 41/M 14.2 14.0 5.1 5.1 14 22 6800 6600 
3 I3240 Mrs.Selvi 42/F 13.5 138 4.6 4.6 4 8 5100 4500 
4 H96706 Mrs.Madhavi 50/F 15.1 15.5 4.5 4.5 4 6 5500 6700 
5 I6186 Mrs.Kumari 56/F 13.5 13.8 4.5 4.5 12 8 6500 7000 
6 I7514 Mr.Srinivasan 53/M 13.9 14.2 5.0 5.0 10 22 6500 6500 
7 I8998 Mrs.Shyamala gowri 38/F 11.3 12.0 4.4 4.4 66 30 10000 8500 
8 I9177 Mrs.Amsavalli 38/F 12.5 12.2 4.6 4.2 62 30 7500 7000 
9 H43605 Mrs.Rajeshwari 34/F 10 10.2 4.2 4.0 4 8 10200 8500 
10 I16170 Mrs.Kavitha 41/F 13.0 13.5 4.0 4.1 10 12 6300 6300 
11 I14042 Mrs.Amutha 40/F 12.2 12.4 4.3 4.4 34 40 6100 6300 
12 I22127 Mr.Devaraj 30/M 15.9 16.7 6.4 6.4 6 8 5600 5000 
13 H88529 Mrs.S.Sudha 30/F 13.7 13.7 4.5 4.5 10 12 6300 6900 
14 I7243 Mrs.Geetha 33/F 13.5 13.0 4.5 4.5 12 14 4500 5000 
15 I25806 Mr.Lindo 23/F 14.2 15.3 5.0 5.4 16 6 4000 4000  
16 I27407 Mrs.Nazeera 40/F 11.9 12.8 5.1 5.3 40 30 6600 6000 
17 I33890 Mrs.Mahalakshmi 36/F 12.5 12.8 4.5 4.6 6 4 6000 6500 
18 I13101 Mrs.Kasthuri 27/F 12.6 12.6 5.2 5.2 34 12 7900 7800 
19 H91313 Mr.Elumalai 46/M 15.9 16.2 4.4 4.6 4 12 4400 4200 
20 I37733 Mr.Velmurugan 54/M 15.6 15.3 5.1 4.9 6 8 8200 7800 
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LABORATORY INVESTIGATION OP AND IP- BEFORE AND AFTER 
TREATMENT 
 Hb(gm/dl) TOTAL 
RBC 
COUNT 
(million/c
u.mm) 
ESR 
(mm/hour
) 
TOTAL WBC 
COUNT 
S.N
O 
IP/OP 
NO 
 NAME AGE/ 
SEX 
BT AT BT AT BT AT BT AT 
21 IP8546 Mrs.Shanthi 43/F 10.5 11.5 3.9 3.9 40 38 8000 7600 
22 I38893 Mrs.Salmabeevi 57/F 12.8 12.8 4.5 4.5 42 22 8900 7800 
23 I20360 Mrs.Malarvizhi 50/F 12.1 12.3 4.6 4.6 16 40 4600 5300 
24 H69278 Mrs.Vijaya 44/F 10.2 10.5 4.7 4.5 62 32 7800 7500 
25 IP8576 Mrs.Chandra 54/F 11.4 11.6 3.9 3.9 82 80 7400 8600 
26 I53175 Mrs.Padma 36/F 12.9 13.0 4.4 4.4 20 22 7300 7400 
27 I48839 Mrs.Bharathi 54/F 12.3 12.5 4.0 4.1 24 60 5300 5900 
28 I45309 Mrs.S.Sudha 45/F 12.9 12.0 4.5 4.2 24 26 5200 5200 
29 I20358 Mrs.Srividhya 45/F 12.5 12.8 4.5 4.5 6 8 5500 6000 
30 I41992 Mrs.Yasodha 37/F 12.2 12.2 4.8 4.8 6 6 6600 6300 
31 I48370 Mrs.B.Shanthi 54/F 13.5 13.5 4.5 4.5 20 30 4600 4600 
32 I59044 Mrs.Kalaivani 45/F 13.3 13.6 4.8 4.8 6 8 8700 6700 
33 I58557 Mrs.Parameshwari 36/F 12.9 12.9 4.6 4.6 8 4 7700 6500 
34 I58557 Mrs.Manjula 43/F 12.9 12.9 4.4 4.4 24 20 8000 8000 
35 I59041 Mrs.Poonguzhali 34/F 12.9 12.8 4.6 4.6 24 12 9700 7400 
36 I52794 Mrs.Sundari 40/F 11.5 12.0 4.5 4.5 6 8 4500 6000 
37 I60014 Mrs.Srimathi 48/F 13.8 12.8 4.7 4.4 12 60 6500 6300 
38 G85168 Mrs.Gajalakshmi 30/F 11.9 12.0 4.7 4.7 20 12 9100 6700 
39 I65089 Mrs.Narmadha 53/F 12.5 12.0 4.9 4.9 46 34 10000 1060
0 
40 I49734 Mrs.Sasikala 43/F 11.9 11.9 4.3 4.2 32 70 6500 6200 
 
 
89 
 
LABORATORY INVESTIGATION OP AND IP- BEFORE AND AFTER 
TREATMENT 
 BLOOD 
GLUCOS
E(F) 
BLOOD 
GLUCOS
E(PP) 
UREA CREATIN
INE 
TOTAL 
CHOLES
TROL 
S.
N
O 
IP/OP 
NO 
 NAME AGE/ 
SEX 
BT AT BT AT BT AT BT AT BT AT 
1 H88414 Mrs.Chitra 43/F 78 78 17 110 15 15 1.1 0.9 197 180 
2 G60332 Mr. Prakash 41/M 108 75 115 101 18 17 1.2 1.1 169 158 
3 I3240 Mrs.Selvi 42/F 85 75 102 82 16 12 1.0 0.8 138 151 
4 H96706 Mrs.Madhavi 50/F 95 90 110 110 16 15 0.9 0.8 165 168 
5 I6186 Mrs.Kumari 56/F 90 88 110 99 16 15 0.8 0.8 165 163 
6 I7514 Mr.Srinivasan 53/M 107 84 136 98 24 17 1.0 0.9 152 121 
7 I8998 Mrs.Shyamala 
gowri 
38/F 91 85 110 100 22 18 1.0 0.8 163 160 
8 I9177 Mrs.Amsavalli 38/F 110 81 108 91 22 17 1.0 0.7 194 172 
9 H43605 Mrs.Rajeshwari 34/F 90 74 123 109 13 15 0.9 0.9 164 166 
10 I16170 Mrs.Kavitha 41/F 92 92 138 119 09 15 1.0 0.9 195 167 
11 I14042 Mrs.Amutha 40/F 90 4 86 88 21 18 0.8 0.7 191 164 
12 I22127 Mr.Devaraj 30/M 100 88 126 107 17 20 0.8 0.9 162 111 
13 H88529 Mrs.S.Sudha 30/F 111 70 140 100 29 21 1.1 0.9 176 157 
14 I7243 Mrs.Geetha 33/F 85 90 100 110 16 16 0.8 0.8 155 160 
15 I25806 Mr.Lindo 23/F 105 103 114 110 12 15 1.1 0.9 164 145 
16 I27407 Mrs.Nazeera 40/F 103 106 100 116 14 13 0.9 0.8 162 154 
17 I33890 Mrs.Mahalaksh
mi 
36/F 80 85 100 125 16 13 0.8 0.7 165 155 
18 I13101 Mrs.Kasthuri 27/F 79 105 77 89 13 15 0.7 0.7 147 143 
19 H91313 Mr.Elumalai 46/M 88 105 75 110 20 17 0.8 0.8 196 182 
20 I37733 Mr.Velmurugan 54/M 75 93 101 100 31 23 1.0 1.0 201 193 
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LABORATORY INVESTIGATION OP AND IP- BEFORE AND AFTER 
TREATMENT 
 BLOOD 
GLUCOS
E(F) 
BLOOD 
GLUCOS
E(PP) 
UREA CREATIN
INE 
TOTAL 
CHOLES
TROL 
S.
N
O 
IP/OP 
NO 
 NAME AGE/ 
SEX 
BT AT BT AT BT AT BT AT BT AT 
21 IP8546 Mrs.Shanthi 43/F 110 101 120 105 18 15 0.9 0.8 190 189 
22 I38893 Mrs.Salmabeevi 57/F 71 98 88 105 19 19 0.8 0.8 221 213 
23 I20360 Mrs.Malarvizhi 50/F 68 95 77 132 17 17 0.9 0.9 175 147 
24 H69278 Mrs.Vijaya 44/F 75 94 87 120 18 15 0.8 0.8 165 170 
25 IP8576 Mrs.Chandra 54/F 68 104 135 140 15 14 0.9 0.8 137 170 
26 I53175 Mrs.Padma 36/F 77 96 85 140 15 21 0.9 0.9 156 132 
27 I48839 Mrs.Bharathi 54/F 84 110 84 113 13 14 0.9 0.8 237 236 
28 I45309 Mrs.S.Sudha 45/F 67 94 83 110 19 15 0.8 0.8 160 138 
29 I20358 Mrs.Srividhya 45/F 80 75 110 100 15 13 0.9 0.8 163 155 
30 I41992 Mrs.Yasodha 37/F 87 92 95 115 20 21 0.9 0.9 184 153 
31 I48370 Mrs.B.Shanthi 54/F 90 85 110 115 16 15 0.9 0.8 150 150 
32 I59044 Mrs.Kalaivani 45/F 92 90 108 108 17 20 0.9 0.9 148 171 
33 I58557 Mrs.Parameshw
ari 
36/F 92 90 100 100 19 17 0.8 0.7 157 160 
34 I58557 Mrs.Manjula 43/F 100 90 100 92 12 13 0.7 0.8 185 157 
35 I59041 Mrs.Poonguzhal
i 
34/F 96 98 100 103 11 16 0.8 0.9 149 161 
36 I52794 Mrs.Sundari 40/F 85 90 100 110 16 16 0.8 0.8 158 150 
37 I60014 Mrs.Srimathi 48/F 107 96 110 98 15 17 1.0 1.0 181 197 
38 G85168 Mrs.Gajalakshm
i 
30/F 108 100 114 120 17 17 0.8 0.7 180 178 
39 I65089 Mrs.Narmadha 53/F 95 95 112 120 26 24 0.8 0.9 208 200 
40 I49734 Mrs.Sasikala 43/F 104 96 134 101 20 20 0.8 0.9 192 192 
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LABORATORY INVESTIGATION OP AND IP- BEFORE AND AFTER 
TREATMENT 
 TOTAL 
BILIRUBIN 
CALCIU
M 
PHOSPHO
RUS 
URIC ACID 
S.N
O 
IP/OP 
NO 
 NAME AGE/ 
SEX 
BT AT BT AT BT AT BT AT 
1 H88414 Mrs.Chitra 43/F 0.6 0.5 9.1 9.1 2.8 2.8 5.0 3.5 
2 G60332 Mr. Prakash 41/M 0.4 0.4 8.3 8.4 3.7 4.4 9.4 8.2 
3 I3240 Mrs.Selvi 42/F 1.4 0.8 9.4 8.2 3.1 3.6 4.5 3.6 
4 H96706 Mrs.Madhavi 50/F 0.5 0.6 9.9 9.9 3.5 3.5 5.5 3.9 
5 I6186 Mrs.Kumari 56/F 0.4 0.4 8.9 9.2 2.5 3.1 4.5 4.0 
6 I7514 Mr.Srinivasan 53/M 0.6 0.5 9.7 9.3 2.9 3.4 6.3 5.2 
7 I8998 Mrs.Shyamala gowri 38/F 0.6 0.6 8.9 8.5 2.7 2.5 5.8 4.5 
8 I9177 Mrs.Amsavalli 38/F 1.2 1.0 9.4 8.6 2.1 4.0 3.3 2.4 
9 H43605 Mrs.Rajeshwari 34/F 0.3 0.3 8.4 8.5 3.1 2.9 5.9 6.2 
10 I16170 Mrs.Kavitha 41/F 0.4 0.5 8.7 8.7 2.3 3.2 4.1 4.5 
11 I14042 Mrs.Amutha 40/F 0.4 0.4 9.0 9.3 2.9 3.6 4.8 3.9 
12 I22127 Mr.Devaraj 30/M 1.0 0.8 8.0 8.0 1.8 2.6 6.5 4.6 
13 H88529 Mrs.S.Sudha 30/F 0.7 0.9 9.5 9.4 2.3 2.9 3.8 3.1 
14 I7243 Mrs.Geetha 33/F 0.4 0.5 9.5 9.2 2.9 2.9 3.5 3.3 
15 I25806 Mr.Lindo 23/F 0.6 0.5 8.7 9.2 3.4 3.7 7.9 6.0 
16 I27407 Mrs.Nazeera 40/F 0.5 0.6 7.9 8.4 3.7 3.1 5.3 3.6 
17 I33890 Mrs.Mahalakshmi 36/F 0.3 0.3 9.5 9.3 2.5 2.5 4.5 3.3 
18 I13101 Mrs.Kasthuri 27/F 0.9 0.3 8.0 8.1 3.2 2.9 2.4 2.3 
19 H91313 Mr.Elumalai 46/M 0.4 0.4 8.8 8.2 4.0 4.0 3.1 3.0 
20 I37733 Mr.Velmurugan 54/M 0.4 0.5 8.7 8.1 2.7 2.6 7.6 5.8 
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LABORATORY INVESTIGATION OP AND IP- BEFORE AND AFTER 
TREATMENT 
 TOTAL 
BILIRUBIN 
CALCIUM PHOSPHO
RUS 
URIC ACID 
S.N
O 
IP/OP 
NO 
 NAME AGE/ 
SEX 
BT AT BT AT BT AT BT AT 
21 IP8546 Mrs.Shanthi 43/F 1.2 1.2 7.9 8.9 3.6 3.8 4.5 3.4 
22 I38893 Mrs.Salmabeevi 57/F 0.5 0.5 9.3 9.0 3.7 3.8 4.4 4.1 
23 I20360 Mrs.Malarvizhi 50/F 0.3 0.3 8.5 8.7 3.8 2.9 5.7 5.5 
24 H69278 Mrs.Vijaya 44/F 0.3 0.4 8.8 8.7 3.1 3.4 4.5 6.8 
25 IP8576 Mrs.Chandra 54/F 0.3 0.4 8.2 8.9 3.3 3.7 3.0 3.4 
26 I53175 Mrs.Padma 36/F 0.3 0.3 7.8 7.6 3.5 3.2 3.9 4.4 
27 I48839 Mrs.Bharathi 54/F 0.7 0.7 8.6 8.5 4.0 3.4 3.0 3.2 
28 I45309 Mrs.S.Sudha 45/F 1.0 0.4 8.2 7.6 3.0 2.9 2.9 2.6 
29 I20358 Mrs.Srividhya 45/F 0.5 0.4 8.5 8.5 3.4 3.4 4.4 3.4 
30 I41992 Mrs.Yasodha 37/F 0.4 0.3 8.7 8.2 3.0 2.7 3.9 3.3 
31 I48370 Mrs.B.Shanthi 54/F 0.5 0.6 9.5 9.5 3.8 3.8 4.2 3.8 
32 I59044 Mrs.Kalaivani 45/F 1.2 1.3 75 8.8 2.5 3.0 4.0 4.8 
33 I58557 Mrs.Parameshwari 36/F 0.9 0.5 8.1 8.2 4.6 4.6 2.3 2.3 
34 I58557 Mrs.Manjula 43/F 0.4 0.3 7.5 9.5 2.8 3.3 3.6 3.0 
35 I59041 Mrs.Poonguzhali 34/F 0.9 0.7 8.0 10.2 2.4 3.2 4.3 4.3 
36 I52794 Mrs.Sundari 40/F 0.2 0.2 9.5 9.8 2.9 3.1 3.8 3.6 
37 I60014 Mrs.Srimathi 48/F 0.4 0.4 9.3 8.9 3.0 3.6 3.5 3.9 
38 G85168 Mrs.Gajalakshmi 30/F 0.9 0.6 8.4 9.0 3.3 3.5 5.0 4.5 
39 I65089 Mrs.Narmadha 53/F 0.5 0.5 8.7 8.8 2.9 3.0 3.9 4.5 
40 I49734 Mrs.Sasikala 43/F 0.4 0.4 7.9 8.6 3.7 3.7 5.7 5.5 
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LABORATORY INVESTIGATION OP AND IP- BEFORE AND AFTER 
TREATMENT 
 SGOT SGPT ALKALINE 
PHOSPHAT
ASE 
S.N
O 
IP/OP 
NO 
 NAME AGE/ 
SEX 
BT AT BT AT BT AT 
1 H88414 Mrs.Chitra 43/F 17 17 20 20 76 76 
2 G60332 Mr. Prakash 41/M 20 43 34 27 73 52 
3 I3240 Mrs.Selvi 42/F 17 11 18 08 44 39 
4 H96706 Mrs.Madhavi 50/F 18 15 15 15 75 75 
5 I6186 Mrs.Kumari 56/F 17 15 18 17 65 70 
6 I7514 Mr.Srinivasan 53/M 19 21 23 25 81 64 
7 I8998 Mrs.Shyamala gowri 38/F 11 15 19 20 96 98 
8 I9177 Mrs.Amsavalli 38/F 40 18 32 14 100 62 
9 H43605 Mrs.Rajeshwari 34/F 11 14 14 15 69 61 
10 I16170 Mrs.Kavitha 41/F 19 22 18 15 72 61 
11 I14042 Mrs.Amutha 40/F 18 14 11 09 82 81 
12 I22127 Mr.Devaraj 30/M 17 27 21 29 74 73 
13 H88529 Mrs.S.Sudha 30/F 17 15 19 20 75 73 
14 I7243 Mrs.Geetha 33/F 18 18 20 22 85 89 
15 I25806 Mr.Lindo 23/F 23 17 25 17 95 92 
16 I27407 Mrs.Nazeera 40/F 19 14 16 14 71 71 
17 I33890 Mrs.Mahalakshmi 36/F 17 17 18 18 83 87 
18 I13101 Mrs.Kasthuri 27/F 15 13 06 09 62 74 
19 H91313 Mr.Elumalai 46/M 18 18 18 18 80 82 
20 I37733 Mr.Velmurugan 54/M 19 19 27 26 79 80 
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LABORATORY INVESTIGATION OP AND IP- BEFORE AND AFTER 
TREATMENT 
 SGOT SGPT ALKALINE 
PHOSPHAT
ASE 
S.N
O 
IP/OP 
NO 
 NAME AGE/ 
SEX 
BT AT BT AT BT AT 
21 IP8546 Mrs.Shanthi 43/F 15 15 14 13 58 57 
22 I38893 Mrs.Salmabeevi 57/F 14 15 13 15 67 74 
23 I20360 Mrs.Malarvizhi 50/F 20 16 13 15 52 52 
24 H69278 Mrs.Vijaya 44/F 34 31 15 16 80 70 
25 IP8576 Mrs.Chandra 54/F 12 10 10 17 50 55 
26 I53175 Mrs.Padma 36/F 10 10 11 12 42 44 
27 I48839 Mrs.Bharathi 54/F 14 15 21 16 61 61 
28 I45309 Mrs.S.Sudha 45/F 21 15 24 14 138 118 
29 I20358 Mrs.Srividhya 45/F 15 19 18 20 85 90 
30 I41992 Mrs.Yasodha 37/F 19 15 09 12 56 65 
31 I48370 Mrs.B.Shanthi 54/F 15 15 20 18 80 85 
32 I59044 Mrs.Kalaivani 45/F 09 12 15 14 52 54 
33 I58557 Mrs.Parameswari 36/F 15 16 17 17 75 80 
34 I58557 Mrs.Manjula 43/F 16 15 27 18 88 92 
35 I59041 Mrs.Poonguzhali 34/F 26 26 30 30 80 80 
36 I52794 Mrs.Sundari 40/F 17 15 16 18 150 158 
37 I60014 Mrs.Srimathi 48/F 18 2 15 22 75 75 
38 G85168 Mrs.Gajalakshmi 30/F 17 17 21 21 80 80 
39 I65089 Mrs.Narmadha 53/F 13 15 17 16 107 118 
40 I49734 Mrs.Sasikala 43/F 14 14 14 14 93 103 
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LABORATORY INVESTIGATION OP AND IP- BEFORE AND AFTER 
TREATMENT 
 URINE 
SUGUR(R) 
URINE 
SUGUR(P
P) 
ALBUMI
N 
DEPOSITS 
Epithelia
l cells 
Pus cells 
S.
N
O 
IP/OP 
NO 
 NAME AGE/ 
SEX 
BT AT BT AT BT AT BT AT BT AT 
1 H88414 Mrs.Chitra 43/F NIL NIL NIL NIL NIL NIL 1-3 1-3 1-2 1-2 
2 G60332 Mr. Prakash 41/M NIL NIL NIL NIL NIL NIL 1-3 1-3 1-3 1-3 
3 I3240 Mrs.Selvi 42/F NIL NIL NIL NIL NIL NIL 1-3 1-3 1-2 1-2 
4 H96706 Mrs.Madhavi 50/F NIL NIL NIL NIL NIL NIL 2-3 1-3 1-2 1-2 
5 I6186 Mrs.Kumari 56/F NIL NIL NIL NIL NIL NIL 1-3 1-3 1-3 1-3 
6 I7514 Mr.Srinivasan 53/M NIL NIL NIL NIL NIL NIL 2-4 2-4 1-3 1-2 
7 I8998 Mrs.Shyamala 
gowri 
38/F NIL NIL NIL NIL NIL NIL 1-3 1-4 1-2 1-3 
8 I9177 Mrs.Amsavalli 38/F NIL NIL NIL NIL NIL NIL 1-3 1-3 1-2 1-2 
9 H43605 Mrs.Rajeshwari 34/F NIL NIL NIL NIL NIL NIL 1-3 1-3 2-3 2-3 
10 I16170 Mrs.Kavitha 41/F NIL NIL NIL NIL NIL NIL 2-4 2-4 1-3 1-3 
11 I14042 Mrs.Amutha 40/F NIL NIL NIL NIL NIL NIL 2-4 2-4 1-3 1-2 
12 I22127 Mr.Devaraj 30/M NIL NIL NIL NIL NIL NIL 2-3 1-2 2-3 1-2 
13 H88529 Mrs.S.Sudha 30/F NIL NIL NIL NIL NIL NIL 4-6 4-6 2-3 2-3 
14 I7243 Mrs.Geetha 33/F NIL NIL NIL NIL NIL NIL 1-3 1-3 1-2 1-2 
15 I25806 Mr.Lindo 23/F NIL NIL NIL NIL NIL NIL 1-3 1-3 2-3 2-3 
16 I27407 Mrs.Nazeera 40/F NIL NIL NIL NIL NIL NIL 3-5 1-2 1-3 1-3 
17 I33890 Mrs.Mahalaksh
mi 
36/F NIL NIL NIL NIL NIL NIL 1-3 1-4 2-3 2-3 
18 I13101 Mrs.Kasthuri 27/F NIL NIL NIL NIL NIL NIL 2-3 2-3 1-2 1-2 
19 H91313 Mr.Elumalai 46/M NIL NIL NIL NIL NIL NIL 1-2 1-2 1-2 1-2 
20 I37733 Mr.Velmurugan 54/M NIL NIL NIL NIL NIL NIL 1-2 1-2 1-3 1-3 
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LABORATORY INVESTIGATION OP AND IP- BEFORE AND AFTER 
TREATMENT 
 URINE 
SUGUR(R) 
URINE 
SUGUR(P
P) 
ALBUMI
N 
DEPOSITS 
Epithelia
l cells 
Pus cells 
S.
N
O 
IP/OP 
NO 
 NAME AGE/ 
SEX 
BT AT BT AT BT AT BT AT BT AT 
21 IP8546 Mrs.Shanthi 43/F NIL NIL NIL NIL NIL NIL 1-3 1-5 1-2 1-3 
22 I38893 Mrs.Salmabeevi 57/F NIL NIL NIL NIL NIL NIL 1-2 1-2 1-3 1-3 
23 I20360 Mrs.Malarvizhi 50/F NIL NIL NIL NIL NIL NIL 1-2 1-3 1-2 1-2 
24 H69278 Mrs.Vijaya 44/F NIL NIL NIL NIL NIL NIL 2-4 4-5 3-5 1-3 
25 IP8576 Mrs.Chandra 54/F NIL NIL NIL NIL NIL NIL 1-3 1-3 1-2 1-2 
26 I53175 Mrs.Padma 36/F NIL NIL NIL NIL NIL NIL 1-2 1-2 2-3 2-3 
27 I48839 Mrs.Bharathi 54/F NIL NIL NIL NIL NIL NIL 1-3 1-3 1-2 1-2 
28 I45309 Mrs.S.Sudha 45/F NIL NIL NIL NIL NIL NIL 1-2 1-2 1-3 2-5 
29 I20358 Mrs.Srividhya 45/F NIL NIL NIL NIL NIL NIL 1-3 1-3 2-3 2-3 
30 I41992 Mrs.Yasodha 37/F NIL NIL NIL NIL NIL NIL 1-2 2-3 2-3 3-4 
31 I48370 Mrs.B.Shanthi 54/F NIL NIL NIL NIL NIL NIL 1-3 1-5 1-2 1-2 
32 I59044 Mrs.Kalaivani 45/F NIL NIL NIL NIL NIL NIL 2-4 2-4 1-3 1-3 
33 I58557 Mrs.Parameshw
ari 
36/F NIL NIL NIL NIL NIL NIL 1-3 1-3 1-2 1-2 
34 I58557 Mrs.Manjula 43/F NIL NIL NIL NIL NIL NIL 1-2 4-6 2-3 2-3 
35 I59041 Mrs.Poonguzhal
i 
34/F NIL NIL NIL NIL NIL NIL 1-3 1-3 2-4 2-3 
36 I52794 Mrs.Sundari 40/F NIL NIL NIL NIL NIL NIL 1-4 1-5 2-3 1-3 
37 I60014 Mrs.Srimathi 48/F NIL NIL NIL NIL NIL NIL 1-3 1-4 2-4 1-2 
38 G85168 Mrs.Gajalakshm
i 
30/F NIL NIL NIL NIL NIL NIL 1-3 1-3 1-2 1-2 
39 I65089 Mrs.Narmadha 53/F NIL NIL NIL NIL NIL NIL 1-3 1-3 1-2 1-2 
40 I49734 Mrs.Sasikala 43/F NIL NIL NIL NIL NIL NIL 1-3 1-3 1-2 1-2 
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Statistical Analysis 
 
All collected data were entered into MS Excel software using different columns as 
variables and rows as patients. SPSS software was used to perform statistical analysis. Basic 
descriptive statistics include frequency distributions and cross-tabulations were performed. 
The quantity variables were expressed as Mean ± Standard Deviation and qualitative data as 
percentage. A probability value of <0.05 was considered to indicate as statistical significance. 
Paired„t‟ test was performed for determining the significance between before and after 
treatment. 
  
PAIN ASSESSMENT SCALE BEFORE AND AFTER TREATMENT 
 
Table: Statistical Significance Of Treatment On Pain 
 
Pain scale Sample size Mean± 
Standard 
Deviation 
T Value P value 
Before 
treatment 
  40 7.3±1.48  
19.8 
 
<0.0001 
After 
treatment 
40 1.8±2.52 
 
There was a significant difference between before and after treatment on Pain in pain score 
i.e., significant reduction - 75% in after treatment. 
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DISCUSSION 
 
The Retrospective review of the disease Kuthikaal vaatham mentioned in Siddha 
literatures begins from the correlation of its signs and symptoms of the disease with Plantar 
Fasciitis.  
 The drugs which possess anti-vaatha property as mentioned in Siddha literature were 
selected and the trial drugs were prepared by the Author in the Gunapadam practical 
laboratory of National Institute of Siddha, after getting proper authentication of raw drugs 
from the Medicinal Botany Department under the supervision of the members of the faculties 
and guided by the Head of the Department of Sirappu Maruthuvam of the National Institute 
of Siddha, Chennai - 47.  
 40 patients of both genders were recruited for this study. The treatment was aimed to 
normalizing the deranged thodams and providing relief from symptoms. Before treatment the 
patients were advised to take Meganatha Kuligai – 2 pills with hot water in empty stomach at 
early morning for purgation. The patient was advised to take rest without internal medicine 
and other activities on that day. 
From next day onwards the patients were treated with trial drugs „Akkini 
Chooranam’ twice a day with hot water and Veera Mezhugu external for 48 days. Patients 
were instructed to take the Medicines regularly advised to follow pathiyam (avoid tamarind, 
tubers, etc) and advised to avoid weight bearing, and prolonged standing. Out-Patients were 
asked to visit the hospital once in 7 days. For Out-Patients the drugs were given for 48 days 
and the clinical assessment was done under the supervision of the faculty on 1
st
 day, 8
th
 day, 
15
th
 day, 22
th
 day , 29
th
 day, 36
th
 day, 43
th
 day and 49
th
 day. For In-Patients the trial drugs 
were given for 48 days and the clinical assessment was done daily. For In-Patients, who are 
not in a situation to stay in the hospital for a long time, were advised to attend the Out-Patient 
Department of Sirappu Maruthuvam for further follow- up.  
  After the fulfillment of treatment, the patients were advised to visit the Out-Patient 
Department of Sirappu Maruthuvam for further follow-up.  
              Among the 40 cases, 6 (15%) cases were males and 34 (85%) cases were females. In 
this study majority affected sex is female (85%). The one of the common cause for this may 
be depletion of calcium from their body and increased house hold works. From history taking 
these were concluded as the reasons for female predominance. 
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              This study shows that the highest age distribution of Kuthikaal Vaatham is between 
41-50 years of age. 
              Most of the patients under this analysis were predominantly of Raso gunam assessed 
from interrogation and other observations.  
              Most of the patients 36 (90%) were non vegetarians. Non vegetarian diet may be the 
cause for deposition of fat in adipose tissue and there by promoting obesity. This alters the 
weight transferring mechanism in heel, causing this disease. 
                In Vaatham Viyanan and Samanan were affected in all 40 cases. Abanan was 
affected in 4 cases and Devathathan in 8 cases.  
  In Pitham Saathaga pitham was affected in all the 40 cases. Ranjaga pitham was 
affected in 3 cases. 
  In Kabam Avalambagam and Santhigam was affected in all the 40 cases. 
 All cases were observed and examined by the eight clinical parameters of Siddha 
system.  
 Naadi (Pulse reading) was observed in all 40 patients. 22 cases had Vaathapittham, 
8 cases had Pithavatham, 2 cases had Pithakabam and 8 cases had Kabapitham naadi.  
In Malam 4 cases (10%) had constipation. 
The color of the urine was Elamanjal niram (Pale yellow coloured urine) and Manjal 
(dark yellow).  
In Neikkuri (Oil on urine sign) examination, oil spreads slowly in 18 cases indicates 
vitiation of vatham in the Kuthikaal vaatham patients, in 12 cases it appeared like ring form 
and in rest of the 10 cases oil acquired as a pearl shape. This reveals that most of the cases 
had derangement in vaatham.  
In Seven Udal kattugal Enbu and Saaram were affected in all 40 cases (100%), 
Senneer was affected in 4 cases (10%), Oon was affected in 10 cases (4%)  Kozhuppu was 
affected in 37 cases (92.5%) and Enbu was affected in 40 (100%) cases. 
 In clinical features Heel pain and early morning pain were present in all the 40 
cases. 35 cases (87.5%) had tenderness in heel region with limitation of movements. The 
other important features were stiffness in 12 cases (30%) and Exacerbation of pain on 
movements in 37 cases (92.5%). 
            Already it was explained that aging is the most common cause for Kuthikaal vaatham. 
Apart from that, increased household works, Obesity and menopause are the other 
precipitating factors. Household work accounts for the highest number 16 (40%) of cases.             
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Laboratory investigation of blood and urine were done for all 40 cases. There were no 
significant changes in blood and urine parameters before and after treatment. In serum uric 
acid level is decreased in some of the cases are noted in the trial. 
             The radiographic study does not show any changes in plantar fasciitis.  It helps to 
detect calcaneal spur and other heel pathologies. The trial drug showed improvement in 
prognosis of the disease clinically. 
             On the basis of curative effect of the trial drugs, Good improvement was assessed in 
27 Patients (67.5%), Moderate improvement was assessed in 6 patients (15%), Mild 
improvement in 4 patients (10%) and No improvement was assessed in 3 patients (7.5%).              
               Based on the Restricted movement assessment scale, among 40 patients, 27 (67.5%) 
patients were reported good relief in restriction of movements, 9 (22.5%) patients were 
reported  moderate relief and restriction of movements continued in remaining 4 (10%) of 
cases. 
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SUMMARY
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SUMMARY 
   
The Protocol of this study has been submitted to IEC of NIS on 26-8-2015 and then 
approval was got from IEC for conducting this clinical study. The IEC NO is 
NIS/IEC/9/2014-15/13. 
This study was registered in Clinical Trial Registry of India and the registration 
number of the Trial is CTRI/2017/06/008931. 
The 40 cases of Kuthikaal Vaatham were Screened and diagnosed clinically and 
treated in Outpatient and In-patient Department of Sirappu Maruthuvam in Ayothidoss 
Pandithar Hospital attached to National Institute of Siddha, Tamabaram Sanatorium and 
Chennai – 47. 
The various Siddha methods of examination of the disease were carried out and the 
data were recorded in the prescribed Proforma for the 40 selected cases.  
 The day before starting treatment purgation was given with Meganatha Kuligai-2 
pills in hot water at early morning. 
From the first day onwards Akkini Chooranam 1.5gm (twice a day) along with 
hotwater was given internally and Veeramezhugu (Q.S) for external use were given to the 
patients. 
 During the period of treatment all the patients were put under Pathiyam (specific 
dietary regimen chat for the disease given to each patient. 
    Laboratory investigations were done periodically for all the cases before and after 
treatment and radiological investigations were done for all the cases before treatment. 
The observations made during the clinical study showed that internal and external 
drugs were effective in relieving the pain in Kuthikaal vaatham patients. During the study 
period, there was no adverse event reported. As per the Siddha Literature and recent research 
articles, the ingredients of the trial drugs was found to have anti inflammatory, 
Immunomodulator , Anti- oxidant, Analgesic properties owing to the disease manifestations. 
  Phytochemical analysis which indicates the presence of tannic acid, calcium, chloride 
has a role in strengthening the bone matrix. 
 Based on the statistical significance, it was observed by the pain scale there is a 
reduction of heel pain reduced from 7.3±1.48 to 1.48±2.52 mean value with significant P 
value of <0.0001.  
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  Hence the trial medicine may effective for Kuthikaal Vaatham. Statistical analysis 
showed significant reduction in the pain score before and after treatment. 
            
  The outcome of the trial medicine assessed by pain scale and the results were as 
follows: 
Good improvement   -  27 patients (67.5%) 
Moderate improvement - 6   patients (15%) 
Mild improvement       - 4   patients (10%) 
No improvement  - 3   patients (7.5%)  
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CONCLUSION  
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Conclusion 
The clinical trial proves the efficacy of the trail drugs by reducing the clinical signs 
and symptoms like heel pain, early morning pain, restricted movements and provides better 
improvement. The study results show that 3 (7.5%) of them had no improvement, 4 (10%) of 
them had mild improvement, 6 (15%) of them had moderate improvement and 27 (67.5%) of 
them had good improvement. Hence these results revealed good relief from the disease after 
treatment. 
The trial Medicines were prepared from easily available ingredients and the 
palatability of medicine is better and the dosage is also convenient. 
In this study, there was no adverse effects were reported in clinical trial. Hence the 
trial drugs were proven for their safety. The clinical trial conducted in selected patients was 
satisfactory encouraging. Further studies may be taken up to establish the efficacy of the 
drugs. 
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI – 600047. 
 
 
AN  OPEN CLINICAL TRIAL OF SIDDHA DRUG “AKKINI CHOORANAM” 
(INTERNAL) AND “VEERA MEZHUGU” (EXTERNAL) IN THE TREATMENT OF 
“KUTHIKAAL VAATHAM” (PLANTAR FASCIITIS). 
 
Principal Investigator: Dr.M.Padmavathi.                                                              
 
FORM I - SCREENING & SELECTION PROFORMA 
 
1. SERIAL NO:      2. OP /IP NO:                              
3. NAME:            4. AGE/GENDER:    
5. OCCUPATION:           6. INCOME:  
 
INCLUSION CRITERIA 
 Whether age is between 20-60                                  YES\ NO  
 Sex                            M \ F 
 Pain in Heel region.                  YES\ NO   
 Restricted movements.                                                     YES\ NO  
 Willing to attend OPD or admission in IPD for the trial   YES\ NO 
 Willingness for consent       YES\ NO 
 Willing to give specimen of blood for the investigation     YES\ NO 
 Willing to undergo radiological investigation                            YES\ NO 
 
EXCLUSION CRITERIA 
 
 Cardiac disease                                                                                   YES\ NO                                                                                     
 Diabetes mellitus       YES\ NO  
 Rheumatoid arthritis       YES\ NO 
 Septic arthritis        YES\ NO 
 Gonococcal arthritis                                                                            YES\ NO  
 Psoriatic arthritis       YES\ NO 
 Pregnancy and lactation      YES\ NO 
 Chronic kidney disease      YES\ NO 
 Patient with any other serious systemic illness   YES\ NO 
 
ADMITTED TO TRAIL 
YES  NO  
If Yes, OPD  IPD  
  Serial NO:  
 
Date:        
Station: 
Signature of the Investigator: 
Signature of the Faculty:                                                           Signature of the HOD   
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS  PANDITHAR HOSPITAL, CHENNAI – 600047. 
 
 
AN  OPEN CLINICAL TRIAL OF SIDDHA DRUG“AKKINI CHOORANAM” (INTERNAL) 
AND “VEERA MEZHUGU” (EXTERNAL) IN THE TREATMENT OF “KUTHIKAAL 
VAATHAM” (PLANTAR FASCIITIS). 
Principal Investigator: Dr.M.Padmavathi                                                              
 
STUDY  NO:   OP / IP NO: 
NAME: AGE / GENDER: 
ADDRESS: CONTACT NO : 
 RELIGION :  H / C / M / O. 
OCCUPATION: INCOME: 
MARITAL STATUS :       1. Married 2. Unmarried 
DATE OF INTIAL ASSESSMENT:  
COMPLAINTS & DURATION:   
FORM II-A – HISTORY TAKING PROFORMA 
                                                                                                                                                                                
PERSONAL HISTORY: 
PERSONAL HABITS YES NO 
IF YES 
SPECIFY 
DURATION 
AMOUNT/Qty 
Smoking     
Tobacco Chewing     
Alcohol     
Narcotic  Drug Addiction     
  
HISTORY OF PREVIOUS ILLNESS AND TREATMENT TAKEN: 
 
FAMILY HISTORY:  
Whether this problem runs in family? 1. Yes            2. No    
If yes, mention the relationship of affected 
person(s) 
1._________________ 
 
2._________________ 
 
 
DIETARY STYLE: 1. Vegetarian    2. Non-vegetarian 
 
 
MENSTURAL AND OBSTETRIC HISTORY: 
 
                                                                                       
 
 
 
 
 
 
DEPARTMENT OF SIRAPPU MARUTHUVAM 
117 
 
                                                     
FORM –II B 
 
GENERAL EXAMINATION: 
1. Body weight [Kg]    :                      
2. Height [cms]                       :                        
3. Body Temperature [F]       :   
4. Blood Pressure (mm/Hg)  :      
5. Pulse Rate /min.        : 
6. Heart Rate / min.         : 
7. Respiratory Rate /min.  :   
                                                                                  Yes            No   
8. Pallor   :   
9. Jaundice   :   
10. Clubbing   : 
11. Cyanosis   : 
12. Pedal Oedema   : 
13. Lymphadenopathy            :                                        
14. Jugular venous pulsation   :   
SYSTEMIC EXAMINATION 
  Cardiovascular system  :  
  Respiratory system   :  
  Gastro-intestinal system  :  
  Central Nervous system  :  
  Urogenital system   :  
  Endocrine system              :  
SIDDHA SYSTEM OF EXAMINATION 
1. THEGI (BODY CONSTITUTION): 
1. Vatha udal      
2. Pitha udal 
3. Kaba udal 
4. Thontha udal 
2. NILAM (LAND WHERE THE PATIENT LIVED MOST):  
1. Kurinji (Hilly terrain) 
2. Mullai (Forest range) 
3. Marutham (Plains) 
4. Neithal (Coastal belt) 
5. Paalai (Aridregion) 
3. KAALAM: 
1. Kaar kaalam    (Aavani-Purattasi) 
2. Koothir kaalam     (Ippasi-Kaarthigai) 
3. Munpani kaalam     (Maargazhi-Thai) 
4. Pinpani kaalam       (Maasi-Panguni) 
5. Ilavenil kaalam        (Chithirai-Vaigasi) 
6. Muthuvenil kaalam (Aani-Aadi) 
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4. GUNAM: 
1. Saththuvam  
2. Rasatham 
3. Thamasam 
 
5. PORIPULANGAL (SENSORY ORGANS):          
                  
  
 
 
 
 
 
 
 
6.KANMENDRIYAM (MOTOR ORGANS) : 
        
 
 
 
 
 
 
 
7.KOSANGAL (SHEATH):                
 
 
 
 
 
 
  
   
 
 
8. SEVEN UDAL THAATHUKKAL (SEVEN SOMATIC COMPONENTS) 
 Before treatment After treatment 
Saaram Normal  /Affected Normal  /Affected 
Senneer  Normal  /Affected Normal  /Affected 
Oon Normal  /Affected Normal  /Affected 
Kozhuppu Normal  /Affected Normal  /Affected 
Enbu Normal  /Affected Normal  /Affected 
Moolai Normal  /Affected Normal  /Affected 
Sukkilam / Suronitham Normal  /Affected Normal  /Affected 
 Before treatment After treatment 
Mei (Skin) Normal  / Affected Normal  / Affected 
Vai (Tongue) Normal  / Affected Normal  / Affected 
Kann (Eye) Normal  / Affected Normal  / Affected 
Mooku (Nose) Normal  / Affected Normal  / Affected 
Sevi (Ear) Normal  / Affected Normal  / Affected 
 Before treatment After treatment 
Kai(Upper limb) Normal  /Affected Normal  /Affected 
Kaal (Lower limb) Normal  /Affected Normal  /Affected 
Vai (Oral cavity)   Normal  /Affected Normal  /Affected 
Eruvai (Anal reg.) Normal  /Affected Normal  /Affected 
Karuvai (Uro-
genital region) 
Normal  /Affected Normal  /Affected 
 Before treatment After treatment 
Annamaya kosam Normal  /Affected Normal  /Affected 
Pranamaya kosam  Normal  /Affected Normal  /Affected 
Manomaya kosam  Normal  /Affected Normal  /Affected 
Vignanamaya kosam  Normal  /Affected Normal  /Affected 
Ananthamaya kosam Normal  /Affected Normal  /Affected 
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9. UYIR THAATHUKKAL: [THREE HUMORS] (VALI/ AZHAL/ IYYAM) 
 
A) VALI 
 
 0
th
 day 8
th
 day 15
th
 day 22
nd
 day 29
th
 day 36
th
 day 43
rd
 day 49
th
 day 
Praanan 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Abaanan 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Samaanan 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Udhaanan 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Viyaanan 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Naagan 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Koorman 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Kirukaran 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Devathathan 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Dhananjeyan 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
 
 
B) AZHAL 
 
 0
th
 day 8
th
 day 15
th
 day 22
nd
 day 29
th
 day 36
th
 day 43
rd
 day 49
th
 day 
Analakam 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Ranjakam  
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Saathakam  
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Prasakam  
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Aalosakam 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
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C) IYYAM 
 
 0
th
 day 8
th
 day 15
th
 day 22
nd
 day 29
th
 day 36
th
 day 43
rd
 day 49
th
 day 
Avalambagam 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Kilethagam 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Pothagam 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Tharpagam 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Santhigam 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
Normal  
/Affected 
 
 
10. ENVAGAI THERVU: [EIGHT TYPES OF EXAMINATION] 
 
I. NAADI: [PULSE PERCEPTION] 
 
NAADI 0
th
  day 8
th 
day
 
15
th 
day 22
nd
day 29
th
day 36
th
  day 43
rd
day 49
th
day 
         
 
II. SPARISAM: [PALPATION] 
 
Day SPARISAM 
0
th
  day  
8
th 
day
  
15
th
  day  
22
nd
  day  
29
th
  day  
36
th
  day  
43
rd
 day  
49
th 
day  
 
III. NAA: [TONGUE] 
 
NAA 0
th
day 8
th
day
 
15
th
day 22
nd
day 29
th
day 36
th
day 43
rd
day 49
th
day 
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IV. NIRAM: [COMPLEXION]   
    1. Vaatham         
     2. Pitham 
      3. Kabam  
 
V. MOZHI: [VOICE] 
      1. High Pitched 
      2. Low Pitched 
      3. Medium Pitched 
 
VI.VIZHI: [EYES] 
VIZHI 0
th
  day 8
th 
day
 
15
th
day 22
nd
day 29
th
day 36
th
  day 43
rd
day 49
th
day 
         
 
VII. MALAM: [BOWEL HABITS / STOOLS] 
 
 Before treatment After treatment 
Niram   
Irugal   
Ilagal   
Others   
 
VIII. MOOTHIRAM [URINE EXAMINATION]  
 
NEERKKURI: 
 
Neerkkuri Before treatment After treatment 
Niram   
Manam   
Edai   
Nurai   
Enjal   
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NEIKKURI:  
 
Neikkuri Before treatment After treatment 
 Aravana needathu/ 
Snake like pattern 
 
  
Azhipol paraviyathu 
Annular/Ringedpattern 
 
 
 
parav paraparavoiyadu 
  
Muththothu ninrathu  
Pearlbeadepattern 
  
Other patterns   
 
CLINICAL EXAMINATION:        
           
LOCOMOTOR SYSTEM: 
 CLINICAL SYMPTOMS: 
Affected heel: Right Left    Both               
Pain in Heel: Mild Moderate   Severe 
Onset:                         Sudden                   Gradual 
 
CLINICAL EXAMINATION OF HEEL   
I.INSPECTION: 
 0
th
 day 8
th
 day 15
th
 day 22
nd
day 29
th
 day 36
th
 day 43
rd
day 49
th
 day 
Swelling 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Deformity 
 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
 
II.PALPATION: 
 0
th
 day 8
th
 day 15
th
 day 22
th
 day 29
th
 day 36
th
 day 43
rd
day 49
th
 day 
Tenderness 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Local heat 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
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III. MOVEMENTS 
 0
th
 day 8
th
 day 15
th
 day 22
nd
day 29
th
 day 36
th
 day 43
rd
day 49
th
 day 
Dorsi 
Flexion 
Normal/ 
Affected 
Normal/ 
Affected 
Normal/ 
Affected 
Normal/ 
Affected 
Normal/ 
Affected 
Normal/ 
Affected 
Normal/ 
Affected 
Normal/ 
Affected 
Extension 
Normal/ 
Affected 
Normal/ 
Affected 
Normal/ 
Affected 
Normal/ 
Affected 
Normal/ 
Affected 
Normal/ 
Affected 
Normal/ 
Affected 
Normal/ 
Affected 
 
IV. JOINT MESUREMENT: 
A. HEALTH ASSESSMENT QUESTIONNAIRE: 
 
 
 0
th
 day 8
th
 day 15
th
 day 22
nd
day 29
th
 day 36
th
 day 43
rd
day 49
th
 day 
PAIN 
A. Early morning  
Stiffness 
        
B. Nature of pain                                             
( Mild/ Moderate/ 
Severe) 
        
C. Aggravating   
factor- 
Movement  
(Yes/No) 
        
D. Relieving factor 
–Rest 
(Yes/No) 
        
E. Tenderness 
(Present/absent) 
        
RESTRICTION 
OF MOVEMENT  
(Fully/Partial/No) 
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B. 
1.  UNIVERSAL PAIN ASSESMENT SCALE: 
 
 
            Grade 0    :   No Pain 
 Grade 1-3 :   Mild pain 
 Grade 4-6 :   Moderate pain 
 Grade 7-10 :   Severe pain 
 
2. RESTRICTED MOVEMENT ASSESSMENT SCALE: 
 
GRADATION OF MOVEMENTS 
GRADE I       - Fit for all activities. Can do their work without support 
GRADE II      - Mild restriction of movements,Mild pain present in heel. 
GRADE III      - Moderate restriction of movements, stiffness pain in heel. 
GRADE IV     - Bed ridden / confined to chair, severe pain.                                    
 
3. QUESTIONNARIE: 
PAIN IN HEEL (Please √ Mark) 
Signs and Symptoms 
Before 
Treatment 
After Treatment 
Yes No  Yes No 
Pain present in getting up in the morning     
Pain present 2 hours after getting up     
Pain present at bedtime     
Pain present throughout the day     
Pain aggravates on standing and walking     
Pain at rest     
Tenderness     
Pain in movements     
                                                                                                             
Date:          
Station: 
Signature of the Investigator: 
Signature of the Faculty:                                                           Signature of the HOD 
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI – 600047 
 
 
AN OPEN CLINICAL TRIAL OF SIDDHA DRUG “AKKINI CHOORANAM” 
(INTERNAL) AND “VEERA MEZHUGU” (EXTERNAL) IN THE TREATMENT OF 
“KUTHIKAAL VAATHAM” (PLANTAR FASCIITIS). 
 
Principal Investigator: Dr.M.Padmavathi 
 
1. SERIAL NO:      2. OP /IP NO:                              
3. NAME:            4. AGE/GENDER: 
 
FORM -III - LABORATORY INVESTIGATIONS 
 
BLOOD INVESTIGATIONS 
NORMAL 
VALUES 
BEFORE 
TREATMENT 
AFTER 
TREATMENT 
Hb( gm/dl) 
M:13-18 
W:11-16 
  
T.RBC(millions cells /Cu.mm) 
M:4.5-6.5 
W:3.5-5.5 
  
ESR (mm) 
½ hr. -   
1 hr. 
M:0-10 
W:0-20 
  
T.WBC (Cells /Cu.mm) 4000-11000   
Differential 
Count (%) 
Polymorphs 40-75   
Lymphocytes 20-35   
Monocytes 2-10   
Eosinophils 1-6   
Basophils 0-1   
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BLOOD INVESTIGATIONS 
NORMAL 
VALUES 
BEFORE 
TREATMENT 
AFTER 
TREATMENT 
Blood 
glucose 
(mg/dl) 
Fasting 70-110   
PP 80-140   
Lipid 
profile 
(mg/dl) 
Serum cholesterol 150-200   
HDL 30-60   
LDL Up to 130   
VLDL 40   
TGL Up to 160   
RFT 
(mg/dl) 
Blood urea 16-50   
Serum creatinine 0.6-1.2   
LFT 
(mg/dl) 
Total bilirubin 0.2-1.2   
Direct bilirubin 0.1-0.2   
Indirect bilirubin 0.2-0.7   
Total protein 6-8   
Serum Albumin 3.5-5.5   
Serum globulin 2-3.5   
SGOT (IU/L) 0-40   
SGPT (IU/L) 0-35   
Alkaline phosphatase (IU/L) 80-290   
 
Serum calcium 9-11   
Serum phosphorus 2-5   
Serum Uric acid 
M:3-9 
W: 2.5-7.5 
  
 CRP   
 ASO titre   
 RA factor   
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B.URINE INVESTIGATIONS: 
 
URINE 
INVESTIGATIONS 
BEFORE TREATMENT AFTER TREATMENT 
Albumin   
Sugar (Fasting) 
        (PP) 
  
Deposits   
 
 
C.RADIOLOGICAL EXAMINATIONS 
X- Ray: Ankle joint with Heel: 
1. Antero posterior  
2. Lateral view 
 
 
 
Date:          
Station: 
Signature of the Investigator: 
Signature of the Faculty:                                                           Signature of the HOD 
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NATIONAL INSTITUTE OF SIDDHA 
   AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI – 600047 
 
 
AN OPEN CLINICAL TRIAL OF SIDDHA DRUG “AKKINI CHOORANAM” 
(INTERNAL) AND “VEERA MEZHUGU” (EXTERNAL) IN THE TREATMENT OF 
“KUTHIKAAL VAATHAM” (PLANTAR FASCIITIS). 
 
 
Principal Investigator: Dr.M.Padmavathi                                                              
 
 
FORM  - IV  (DRUG COMPLIANCE FORM) 
SERIAL NO      :                                         
OP/IP NO          : 
NAME                :                                              
AGE/GENDER : 
DRUGNAME:AKKINI CHOORANAM 
 
Date:        
Station: 
Signature of the Investigator: 
Signature of the Faculty:                                                           Signature of the HOD 
 
DEPARTMENT OF SIRAPPU MARUTHUVAM 
   Day    Date    Morning   Evening   Day     Date    Morning   Evening 
Day 1    Day6    
Day2    Day7    
Day3    Day8    
Day4    Day9    
Day5    Day10    
Day11    Day30    
Day12    Day31    
Day13    Day32    
Day14    Day33    
Day15    Day34    
Day16    Day35    
Day17    Day36    
Day18    Day37    
Day19    Day38    
Day20    Day39    
Day21    Day40    
Day22    Day41    
Day23    Day42    
Day24    Day43    
Day25    Day44    
Day26    Day45    
Day27    Day46    
Day28    Day47    
Day29    Day 48    
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FORM V – PATIENT INFORMATION SHEET 
 
 
Name of Principal Investigator: Dr.M.Padmavathi      
 
Name of the institute: National Institute of Siddha, 
                                      Tambaram Sanatorium, 
                                      Chennai-47. 
 
INFORMATION SHEET FOR PATIENTS PARTICIPATING IN THE OPEN 
CLINICAL TRIAL. 
 
I  Dr.M.Padmavathi Studying M.D (Siddha) at National Institute of Siddha, 
Tambaram Sanatorium is doing a clinical trial on KUTHIKAAL VAATHAM (PLANTAR 
FASCIITIS). In this regard, I am in a need to ask you few questions. I will maintain 
confidentiality of your comments and data obtained. There will be no risk of disclosing your 
identity and no physical, psychological or professional risk is involved by taking part in this 
study. Taking part in this study is voluntary. No compensation will be paid to you for taking 
part in this study. 
 
           You can choose not to take part. You can choose not to answer a specific question. 
There is no specific benefit for you if you take part in the study. However, taking part in the 
study may be of benefit to the community, as it may help us to understand the problem of 
defaulters and potential solutions. 
 
             If you agree to be a participant in this study, you will be included in the study 
primarily by signing the consent form and then you will be given the internal medicine 
AKKINI CHOORANAM (Internal medicine-1.5gm BD with hot water for 48 days) and 
VEERA MEZHUGU (External medicine). 
  The information I am collecting in this study will remain confidential. I will ask you 
few questions through a questionnaire.  
 
If you wish to find out more about this study before taking part, you can ask me all 
the questions you want or contact Dr.M.PADMAVATHI PG Scholar, Ph.no:9092146820 
cum principal investigator of this study, attached to National Institute of Siddha, Chennai-47. 
You can also contact the Member-secretary of Ethics committee, National Institute Siddha, 
Chennai 600047, for rights and participation in the study. 
DEPARTMENT OF SIRAPPU MARUTHUVAM 
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Principal Investigator: Dr. M. Padmavathi   
                                                            
CONSENT FORM    -   FORM VI  
 
“I have read the foregoing information, or it has been read to me. I have had the 
opportunity to ask questions about it and any questions I have asked have been answered 
to my satisfaction.  
            I consent voluntarily to participate as a participant in this study and understand 
that I have the   right to withdraw from the study at any time without in any way it 
affecting my further medical care”. 
 
"I have received a copy of the information sheet/consent form". 
 
Date:  
Signature of the participant 
In case of illiterate participant 
 
        “I have witnessed the accurate reading of the consent form to the potential 
participant, and the individual has had the opportunity to ask questions. I confirm 
individual has given consent freely.”                                                   
 
 
Date: 
 
 
 
Signature of a witness  
(Selected by the participant bearing no connection with the survey team)   
       
          
            
 
 
Left thumb Impression of the Participant 
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FORM VI  ´ôÒ¾ø ÀÊÅõ 
¬öÅ¡ÇÃ¡ø º¡ýÈÇ¢ì¸ôÀð¼Ð 
 
¿¡ý Ì¾¢¸¡ø Å¡¾õ ±ýÛõ §¿¡Â¢ý ¬ö¨Åì ÌÈ¢ò¾ «¨ÉòÐ 
Å¢ÀÃí¸¨ÇÔõ §¿¡Â¡Ç¢ìÌô ÒÃ¢Ôõ Å¨¸Â¢ø ±ÎòÐ¨Ãò§¾ý ±É 
¯Ú¾¢ÂÇ¢ì¸¢§Èý. 
 
 
§¾¾¢:                                      ¨¸¦Â¡ôÀõ: 
                     
þ¼õ:                 ¦ÀÂ÷:                                                
                                         
 
§¿¡Â¡Ç¢Â¢ý ´ôÒ¾ø 
 
±ýÉ¢¼õ  þó¾  ÁÕòÐÅ  ¬öÅ¢ý  ¸¡Ã½ò¨¾Ôõ,  ÁÕó¾¢ý ¾ý¨Á  
ÁüÚõ ÁÕòÐÅ  ÅÆ¢Ó¨È  ÀüÈ¢Ôõ, ¦¾¡¼÷óÐ  ±ÉÐ  ¯¼ø  þÂì¸ò¨¾ì  
¸ñ¸¡½¢ì¸×õ, «¾¨Éô  À¡Ð¸¡ì¸×õ  ÀÂýÀÎõ  ÁÕòÐÅ  ¬ö×ìÜ¼  
ÀÃ¢§º¡¾¨É¸û  ÀüÈ¢  ¾¢Õô¾¢ «Ç¢ìÌõ  Å¨¸Â¢ø  ¬ö×  ÁÕòÐÅÃ¡ø  Å¢Çì¸¢ì  
ÜÈôÀð¼Ð. 
 
¿¡ý  þó¾  ÁÕòÐÅ  ¬öÅ¢ý  §À¡Ð, ¸¡Ã½õ  ±Ð×õ  ÜÈ¡Áø, 
±ô¦À¡ØÐ §ÅñÎÁ¡É¡Öõ  þó¾  ¬öÅ¢Ä¢ÕóÐ   ±ý¨É Å¢ÎÅ¢òÐ  ¦¸¡ûÙõ  
¯Ã¢¨Á¨Âò ¦¾Ã¢ó¾¢Õì¸¢ý§Èý. 
 
¿¡ý  ±ýÛ¨¼Â  Í¾ó¾¢ÃÁ¡¸ò  §¾÷×  ¦ºöÔõ  ¯Ã¢¨Á¨Âì  ¦¸¡ñÎ  
Ì¾¢¸¡ø Å¡¾õ ±ýÛõ §¿¡öìÌ «ì¸¢É¢ ÝÃ½õ (¯û ÁÕóÐ) ÁüÚõ Å£Ã 
¦ÁØÌ  (¦ÅÇ¢ ÁÕóÐ)  ÁÕó¾¢ý ÀÃ¢¸Ã¢ôÒò  ¾¢È¨Éì  ¸ñ¼È¢Ôõ  ÁÕòÐÅ  
¬öÅ¢üÌ  ±ý¨É  ¯ðÀÎò¾ ´ôÒ¾ø  «Ç¢ì¸¢§Èý. 
 
 
§¾¾¢:                                   ¨¸¦Â¡ôÀõ: 
þ¼õ:            ¦ÀÂ÷:         
                                  º¡ðº¢ì¸¡Ã÷ ¨¸¦Â¡ôÀõ: 
                ¦ÀÂ÷:                         
              ¯È×Ó¨È:     
 
 
Å¢Ã¢×¨ÃÂ¡Ç¡÷ ¨¸¦Â¡ôÀõ:             Ð¨Èò¾¨ÄÅ÷ ¨¸¦Â¡ôÀõ: 
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Principal Investigator: Dr.M.Padmavathi    
                                                           
FORM VII - WITHDRAWAL FORM 
 
1. SERIAL NO OF THE CASE: …………………   
2. OP / IP NO: ......................................    
3. NAME: ………………………     
4.AGE: …………        
5.GENDER:...........                           
6. DATE OF TRIAL COMMENCEMENT: ………………... 
7. DATE OF WITHDRAWAL FROM TRIAL: …………….. 
8. REASONS FOR WITHDRAWAL: 
Long absence at reporting:               Yes/ No 
Irregular treatment:                           Yes/ No 
Shift of locality:                                     Yes/No 
Increase in severity of symptoms:     Yes/No 
Development of severe adverse drug reactions:   Yes/No 
Development of adverse event:                                             Yes/No 
(If YES, give the details of adverse reaction in Form IX – Adverse Reaction 
Form / Pharmaco Vigilance Form) 
 
 
 
Date:          
Station: 
Signature of the Investigator: 
Signature of the Faculty:                                                          Signature of the HOD 
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Principal Investigator: Dr.M.Padmavathi  
FORM – VIII DIETARY ADVICE FORM 
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Name of Principal Investigator: Dr.M. Padmavathi      
 
FORM IX – ADVERSE REACTION FORM / PHARMACO VIGILANCE FORM 
 
SERIAL NO:                                                                                                           
OP/IP NO: 
NAME:                                                             AGE:                     GENDER: 
DATE OF TRIAL COMMENCEMENT: 
DATE OF THE ADVERSE REACTION OCCUR: 
DESCRIPTION OF ADVERSE REACTION: 
 
 
 
 
 
 
 
 
 
 
 
 
Date:                                                                              
Station:  
Signature of the Investigator: 
Signature of the Faculty:                                                            Signature of the HOD 
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